Inflamed moods: A review of the interactions between inflammation and mood disorders
Mood disorders have been recognized by the World Health Organization (WHO) as the leading cause of disability worldwide. Notwithstanding the established efficacy of conventional mood agents, many treated individuals continue to remain treatment refractory and/or exhibit clinically significant residu...
Saved in:
| Published in | Progress in neuro-psychopharmacology & biological psychiatry Vol. 53; pp. 23 - 34 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
Amsterdam
Elsevier Inc
04.08.2014
Elsevier |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Mood disorders have been recognized by the World Health Organization (WHO) as the leading cause of disability worldwide. Notwithstanding the established efficacy of conventional mood agents, many treated individuals continue to remain treatment refractory and/or exhibit clinically significant residual symptoms, cognitive dysfunction, and psychosocial impairment. Therefore, a priority research and clinical agenda is to identify pathophysiological mechanisms subserving mood disorders to improve therapeutic efficacy.
During the past decade, inflammation has been revisited as an important etiologic factor of mood disorders. Therefore, the purpose of this synthetic review is threefold: 1) to review the evidence for an association between inflammation and mood disorders, 2) to discuss potential pathophysiologic mechanisms that may explain this association and 3) to present novel therapeutic options currently being investigated that target the inflammatory–mood pathway.
Accumulating evidence implicates inflammation as a critical mediator in the pathophysiology of mood disorders. Indeed, elevated levels of pro-inflammatory cytokines have been repeatedly demonstrated in both major depressive disorder (MDD) and bipolar disorder (BD) patients. Further, the induction of a pro-inflammatory state in healthy or medically ill subjects induces ‘sickness behavior’ resembling depressive symptomatology.
Potential mechanisms involved include, but are not limited to, direct effects of pro-inflammatory cytokines on monoamine levels, dysregulation of the hypothalamic–pituitary–adrenal (HPA) axis, pathologic microglial cell activation, impaired neuroplasticity and structural and functional brain changes.
Anti-inflammatory agents, such as acetyl-salicylic acid (ASA), celecoxib, anti-TNF-α agents, minocycline, curcumin and omega-3 fatty acids, are being investigated for use in mood disorders. Current evidence shows improved outcomes in mood disorder patients when anti-inflammatory agents are used as an adjunct to conventional therapy; however, further research is needed to establish the therapeutic benefit and appropriate dosage.
•Inflammation and mood disorders have a bidirectional interaction.•Cytokines, monoamines, the HPA axis and microglial cells are key players involved.•Anti-inflammatory agents show promise for use in the treatment of mood disorders. |
|---|---|
| AbstractList | Mood disorders have been recognized by the World Health Organization (WHO) as the leading cause of disability worldwide. Notwithstanding the established efficacy of conventional mood agents, many treated individuals continue to remain treatment refractory and/or exhibit clinically significant residual symptoms, cognitive dysfunction, and psychosocial impairment. Therefore, a priority research and clinical agenda is to identify pathophysiological mechanisms subserving mood disorders to improve therapeutic efficacy.
During the past decade, inflammation has been revisited as an important etiologic factor of mood disorders. Therefore, the purpose of this synthetic review is threefold: 1) to review the evidence for an association between inflammation and mood disorders, 2) to discuss potential pathophysiologic mechanisms that may explain this association and 3) to present novel therapeutic options currently being investigated that target the inflammatory–mood pathway.
Accumulating evidence implicates inflammation as a critical mediator in the pathophysiology of mood disorders. Indeed, elevated levels of pro-inflammatory cytokines have been repeatedly demonstrated in both major depressive disorder (MDD) and bipolar disorder (BD) patients. Further, the induction of a pro-inflammatory state in healthy or medically ill subjects induces ‘sickness behavior’ resembling depressive symptomatology.
Potential mechanisms involved include, but are not limited to, direct effects of pro-inflammatory cytokines on monoamine levels, dysregulation of the hypothalamic–pituitary–adrenal (HPA) axis, pathologic microglial cell activation, impaired neuroplasticity and structural and functional brain changes.
Anti-inflammatory agents, such as acetyl-salicylic acid (ASA), celecoxib, anti-TNF-α agents, minocycline, curcumin and omega-3 fatty acids, are being investigated for use in mood disorders. Current evidence shows improved outcomes in mood disorder patients when anti-inflammatory agents are used as an adjunct to conventional therapy; however, further research is needed to establish the therapeutic benefit and appropriate dosage.
•Inflammation and mood disorders have a bidirectional interaction.•Cytokines, monoamines, the HPA axis and microglial cells are key players involved.•Anti-inflammatory agents show promise for use in the treatment of mood disorders. Mood disorders have been recognized by the World Health Organization (WHO) as the leading cause of disability worldwide. Notwithstanding the established efficacy of conventional mood agents, many treated individuals continue to remain treatment refractory and/or exhibit clinically significant residual symptoms, cognitive dysfunction, and psychosocial impairment. Therefore, a priority research and clinical agenda is to identify pathophysiological mechanisms subserving mood disorders to improve therapeutic efficacy. During the past decade, inflammation has been revisited as an important etiologic factor of mood disorders. Therefore, the purpose of this synthetic review is threefold: 1) to review the evidence for an association between inflammation and mood disorders, 2) to discuss potential pathophysiologic mechanisms that may explain this association and 3) to present novel therapeutic options currently being investigated that target the inflammatory-mood pathway. Accumulating evidence implicates inflammation as a critical mediator in the pathophysiology of mood disorders. Indeed, elevated levels of pro-inflammatory cytokines have been repeatedly demonstrated in both major depressive disorder (MDD) and bipolar disorder (BD) patients. Further, the induction of a pro-inflammatory state in healthy or medically ill subjects induces 'sickness behavior' resembling depressive symptomatology. Potential mechanisms involved include, but are not limited to, direct effects of pro-inflammatory cytokines on monoamine levels, dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, pathologic microglial cell activation, impaired neuroplasticity and structural and functional brain changes. Anti-inflammatory agents, such as acetyl-salicylic acid (ASA), celecoxib, anti-TNF-α agents, minocycline, curcumin and omega-3 fatty acids, are being investigated for use in mood disorders. Current evidence shows improved outcomes in mood disorder patients when anti-inflammatory agents are used as an adjunct to conventional therapy; however, further research is needed to establish the therapeutic benefit and appropriate dosage. Mood disorders have been recognized by the World Health Organization (WHO) as the leading cause of disability worldwide. Notwithstanding the established efficacy of conventional mood agents, many treated individuals continue to remain treatment refractory and/or exhibit clinically significant residual symptoms, cognitive dysfunction, and psychosocial impairment. Therefore, a priority research and clinical agenda is to identify pathophysiological mechanisms subserving mood disorders to improve therapeutic efficacy. During the past decade, inflammation has been revisited as an important etiologic factor of mood disorders. Therefore, the purpose of this synthetic review is threefold: 1) to review the evidence for an association between inflammation and mood disorders, 2) to discuss potential pathophysiologic mechanisms that may explain this association and 3) to present novel therapeutic options currently being investigated that target the inflammatory-mood pathway. Accumulating evidence implicates inflammation as a critical mediator in the pathophysiology of mood disorders. Indeed, elevated levels of pro-inflammatory cytokines have been repeatedly demonstrated in both major depressive disorder (MDD) and bipolar disorder (BD) patients. Further, the induction of a pro-inflammatory state in healthy or medically ill subjects induces 'sickness behavior' resembling depressive symptomatology. Potential mechanisms involved include, but are not limited to, direct effects of pro-inflammatory cytokines on monoamine levels, dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, pathologic microglial cell activation, impaired neuroplasticity and structural and functional brain changes. Anti-inflammatory agents, such as acetyl-salicylic acid (ASA), celecoxib, anti-TNF- alpha agents, minocycline, curcumin and omega-3 fatty acids, are being investigated for use in mood disorders. Current evidence shows improved outcomes in mood disorder patients when anti-inflammatory agents are used as an adjunct to conventional therapy; however, further research is needed to establish the therapeutic benefit and appropriate dosage. Mood disorders have been recognized by the World Health Organization (WHO) as the leading cause of disability worldwide. Notwithstanding the established efficacy of conventional mood agents, many treated individuals continue to remain treatment refractory and/or exhibit clinically significant residual symptoms, cognitive dysfunction, and psychosocial impairment. Therefore, a priority research and clinical agenda is to identify pathophysiological mechanisms subserving mood disorders to improve therapeutic efficacy. During the past decade, inflammation has been revisited as an important etiologic factor of mood disorders. Therefore, the purpose of this synthetic review is threefold: 1) to review the evidence for an association between inflammation and mood disorders, 2) to discuss potential pathophysiologic mechanisms that may explain this association and 3) to present novel therapeutic options currently being investigated that target the inflammatory-mood pathway. Accumulating evidence implicates inflammation as a critical mediator in the pathophysiology of mood disorders. Indeed, elevated levels of pro-inflammatory cytokines have been repeatedly demonstrated in both major depressive disorder (MDD) and bipolar disorder (BD) patients. Further, the induction of a pro-inflammatory state in healthy or medically ill subjects induces 'sickness behavior' resembling depressive symptomatology. Potential mechanisms involved include, but are not limited to, direct effects of pro-inflammatory cytokines on monoamine levels, dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, pathologic microglial cell activation, impaired neuroplasticity and structural and functional brain changes. Anti-inflammatory agents, such as acetyl-salicylic acid (ASA), celecoxib, anti-TNF-α agents, minocycline, curcumin and omega-3 fatty acids, are being investigated for use in mood disorders. Current evidence shows improved outcomes in mood disorder patients when anti-inflammatory agents are used as an adjunct to conventional therapy; however, further research is needed to establish the therapeutic benefit and appropriate dosage.Mood disorders have been recognized by the World Health Organization (WHO) as the leading cause of disability worldwide. Notwithstanding the established efficacy of conventional mood agents, many treated individuals continue to remain treatment refractory and/or exhibit clinically significant residual symptoms, cognitive dysfunction, and psychosocial impairment. Therefore, a priority research and clinical agenda is to identify pathophysiological mechanisms subserving mood disorders to improve therapeutic efficacy. During the past decade, inflammation has been revisited as an important etiologic factor of mood disorders. Therefore, the purpose of this synthetic review is threefold: 1) to review the evidence for an association between inflammation and mood disorders, 2) to discuss potential pathophysiologic mechanisms that may explain this association and 3) to present novel therapeutic options currently being investigated that target the inflammatory-mood pathway. Accumulating evidence implicates inflammation as a critical mediator in the pathophysiology of mood disorders. Indeed, elevated levels of pro-inflammatory cytokines have been repeatedly demonstrated in both major depressive disorder (MDD) and bipolar disorder (BD) patients. Further, the induction of a pro-inflammatory state in healthy or medically ill subjects induces 'sickness behavior' resembling depressive symptomatology. Potential mechanisms involved include, but are not limited to, direct effects of pro-inflammatory cytokines on monoamine levels, dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, pathologic microglial cell activation, impaired neuroplasticity and structural and functional brain changes. Anti-inflammatory agents, such as acetyl-salicylic acid (ASA), celecoxib, anti-TNF-α agents, minocycline, curcumin and omega-3 fatty acids, are being investigated for use in mood disorders. Current evidence shows improved outcomes in mood disorder patients when anti-inflammatory agents are used as an adjunct to conventional therapy; however, further research is needed to establish the therapeutic benefit and appropriate dosage. |
| Author | Cha, Danielle S. Mansur, Rodrigo B. Rosenblat, Joshua D. McIntyre, Roger S. |
| Author_xml | – sequence: 1 givenname: Joshua D. surname: Rosenblat fullname: Rosenblat, Joshua D. organization: Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada – sequence: 2 givenname: Danielle S. surname: Cha fullname: Cha, Danielle S. organization: Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada – sequence: 3 givenname: Rodrigo B. surname: Mansur fullname: Mansur, Rodrigo B. organization: Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada – sequence: 4 givenname: Roger S. surname: McIntyre fullname: McIntyre, Roger S. email: roger.mcintyre@uhn.ca organization: Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28559364$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/24468642$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkU1rVDEUhoNU7LT1FwiSjdDNjPm6Sa7gopSqhYKbdh1ykxPMcG9yTe5Y_PdmOlMEF0U4kHB4nrN43zN0knIChN5RsqGEyo_bzZzmYd4wQsWG0Db8FVpRrfRaMCpP0Iqw9u-0kKforNYtIQ0h_A06ZUJILQVbofvbFEY7gcdTzr5-wle4wK8IjzgHvPwAHNMCxbol5lTxAMsjQGrLvTTZ_RbbdJCxjzUXD6VeoNfBjhXeHt9z9PDl5v762_ru-9fb66u7tRNaL-ugLQuMKG89o8ExClzrgSjrrAt91ztFehY6kB6ADRKUkNaBDCzwoEAFfo4uD3fnkn_uoC5mitXBONoEeVcN7YTquFKM_Q8qCFFcyIa-P6K7oQVj5hInW36b59Aa8OEI2OrsGIpNLta_nO66nkvRuP7AuZJrLRCMi8tTZkuxcTSUmH2RZmueijT7Ig2hbXhz-T_u8_mXrc8HC1rqrcViqouQHPhYwC3G5_ii_weqELht |
| CODEN | PNPPD7 |
| CitedBy_id | crossref_primary_10_1016_j_jpsychires_2021_09_054 crossref_primary_10_1016_j_pnpbp_2017_04_035 crossref_primary_10_1016_j_psychres_2018_11_069 crossref_primary_10_1016_j_bbr_2017_05_064 crossref_primary_10_1016_j_bpsc_2022_05_001 crossref_primary_10_1177_1479972316680846 crossref_primary_10_1016_j_bbi_2014_06_016 crossref_primary_10_3934_Neuroscience_2021018 crossref_primary_10_1016_j_pnpbp_2016_09_005 crossref_primary_10_1371_journal_pone_0225778 crossref_primary_10_1186_s13041_014_0085_7 crossref_primary_10_1093_ijnp_pyw019 crossref_primary_10_1016_j_intimp_2023_111046 crossref_primary_10_1111_bdi_12373 crossref_primary_10_1093_ijnp_pyw014 crossref_primary_10_1002_brb3_2472 crossref_primary_10_1177_23727322221145308 crossref_primary_10_1016_j_pnpbp_2017_04_023 crossref_primary_10_1038_s41398_019_0637_9 crossref_primary_10_3390_ijms221810051 crossref_primary_10_1186_s12929_021_00742_6 crossref_primary_10_1134_S1819712424700508 crossref_primary_10_1007_s11011_014_9551_2 crossref_primary_10_1016_j_jad_2015_08_058 crossref_primary_10_1111_bdi_13104 crossref_primary_10_1111_bdi_12496 crossref_primary_10_1016_j_psychres_2018_12_097 crossref_primary_10_1097_MD_0000000000003816 crossref_primary_10_1590_0102_311xen027423 crossref_primary_10_1007_s00403_024_03362_w crossref_primary_10_1016_j_bbr_2023_114295 crossref_primary_10_1186_ar4688 crossref_primary_10_1016_j_yfrne_2019_100783 crossref_primary_10_1177_0004867419888576 crossref_primary_10_7717_peerj_16669 crossref_primary_10_1016_j_drugalcdep_2015_11_024 crossref_primary_10_1007_s11930_019_00218_7 crossref_primary_10_3390_nu13030767 crossref_primary_10_1186_s12888_019_2087_6 crossref_primary_10_3390_ijerph20021602 crossref_primary_10_1016_j_jpsychires_2019_03_030 crossref_primary_10_3892_br_2016_672 crossref_primary_10_1016_j_pscychresns_2021_111351 crossref_primary_10_1007_s00406_017_0792_z crossref_primary_10_1111_jfbc_13291 crossref_primary_10_1186_s12974_019_1475_7 crossref_primary_10_1038_s41598_022_12635_1 crossref_primary_10_1038_srep11412 crossref_primary_10_3390_nu15122809 crossref_primary_10_1111_pai_14249 crossref_primary_10_1080_21641846_2021_2000251 crossref_primary_10_1016_j_phrs_2018_06_015 crossref_primary_10_1016_j_euroneuro_2019_01_091 crossref_primary_10_1016_j_euroneuro_2020_11_016 crossref_primary_10_1097_FBP_0000000000000384 crossref_primary_10_1089_cap_2016_0004 crossref_primary_10_2174_1381612826666201124110437 crossref_primary_10_1016_j_intimp_2021_108415 crossref_primary_10_1016_j_psychres_2021_114086 crossref_primary_10_1038_aps_2016_63 crossref_primary_10_1016_j_neuroscience_2015_05_018 crossref_primary_10_1016_j_bbi_2023_02_021 crossref_primary_10_1016_j_pneurobio_2014_08_002 crossref_primary_10_1186_s12888_022_03702_y crossref_primary_10_1017_S1092852922001043 crossref_primary_10_1186_s12974_018_1341_z crossref_primary_10_1016_j_jpsychires_2019_02_005 crossref_primary_10_1186_s12868_022_00746_4 crossref_primary_10_2174_1381612826666200406090051 crossref_primary_10_3389_fncel_2024_1480405 crossref_primary_10_1186_s12883_024_03760_7 crossref_primary_10_1371_journal_pone_0180601 crossref_primary_10_1002_npr2_12100 crossref_primary_10_1038_s41366_025_01741_5 crossref_primary_10_1016_j_bcp_2022_114963 crossref_primary_10_1016_S0140_6736_20_31544_0 crossref_primary_10_1016_j_psyneuen_2016_05_015 crossref_primary_10_1111_bdi_12324 crossref_primary_10_5498_wjp_v6_i1_84 crossref_primary_10_1016_j_bbi_2017_05_005 crossref_primary_10_1016_j_appet_2018_04_004 crossref_primary_10_1016_j_bbi_2017_05_002 crossref_primary_10_3389_fpsyt_2017_00038 crossref_primary_10_1016_j_pnpbp_2024_111056 crossref_primary_10_1016_j_psychres_2022_114676 crossref_primary_10_1016_j_psyneuen_2018_01_023 crossref_primary_10_1016_j_neuropharm_2022_109366 crossref_primary_10_1016_j_jad_2016_11_035 crossref_primary_10_1007_s40496_014_0020_0 crossref_primary_10_1016_j_bbr_2024_115248 crossref_primary_10_1016_j_euroneuro_2020_10_005 crossref_primary_10_1016_j_jad_2021_05_083 crossref_primary_10_1177_0271678X17747189 crossref_primary_10_1016_j_micinf_2023_105116 crossref_primary_10_1016_j_pnpbp_2019_109648 crossref_primary_10_1080_14656566_2021_1951225 crossref_primary_10_1002_hbm_24441 crossref_primary_10_1007_s11332_021_00753_8 crossref_primary_10_1016_j_dhjo_2016_05_002 crossref_primary_10_3390_ijms22094393 crossref_primary_10_3390_pathogens6010003 crossref_primary_10_1016_j_gendis_2018_05_005 crossref_primary_10_1177_0706743716648296 crossref_primary_10_1016_j_psyneuen_2017_07_003 crossref_primary_10_1016_j_jad_2020_11_128 crossref_primary_10_1007_s00406_023_01720_9 crossref_primary_10_1007_s11481_019_09897_4 crossref_primary_10_1016_j_neubiorev_2021_02_010 crossref_primary_10_1038_s41598_022_20602_z crossref_primary_10_1097_FBP_0000000000000585 crossref_primary_10_1016_j_bbi_2018_11_312 crossref_primary_10_1016_j_jneuroim_2015_12_007 crossref_primary_10_3389_fpsyt_2020_00270 crossref_primary_10_3390_brainsci7110144 crossref_primary_10_1016_j_pharmthera_2022_108282 crossref_primary_10_1016_j_bbih_2020_100167 crossref_primary_10_3389_fmed_2021_771645 crossref_primary_10_1002_gps_4645 crossref_primary_10_1016_j_intimp_2018_11_052 crossref_primary_10_3389_fpsyt_2023_1147298 crossref_primary_10_3390_life13071555 crossref_primary_10_1007_s11892_017_0949_1 crossref_primary_10_1089_cap_2016_0207 crossref_primary_10_3389_fgstr_2022_1019578 crossref_primary_10_1007_s11011_023_01271_x crossref_primary_10_1016_j_ijpsycho_2020_09_011 crossref_primary_10_2174_0113816128251883231031054700 crossref_primary_10_3389_fcvm_2023_1072042 crossref_primary_10_1038_s41398_023_02482_7 crossref_primary_10_1007_s12035_017_0422_9 crossref_primary_10_1093_aje_kww114 crossref_primary_10_1016_j_psychres_2015_06_036 crossref_primary_10_1007_s11033_019_04989_z crossref_primary_10_1177_0004867420965697 crossref_primary_10_1016_j_pnpbp_2020_110032 crossref_primary_10_1038_s41419_020_2626_6 crossref_primary_10_1016_j_jneuroim_2016_10_012 crossref_primary_10_2478_acm_2019_0003 crossref_primary_10_1002_acr_23794 crossref_primary_10_1007_s40519_015_0215_y crossref_primary_10_1016_j_jneuroim_2014_09_007 crossref_primary_10_1016_j_psychres_2016_12_014 crossref_primary_10_3389_fpsyt_2022_844176 crossref_primary_10_1097_MD_0000000000026520 crossref_primary_10_2478_enr_2020_0013 crossref_primary_10_1177_0004867419888027 crossref_primary_10_3390_molecules27061953 crossref_primary_10_1016_j_bbi_2020_05_001 crossref_primary_10_3389_fpsyt_2022_827972 crossref_primary_10_1016_j_heliyon_2023_e16908 crossref_primary_10_1007_s12529_024_10315_0 crossref_primary_10_3390_nu11061361 crossref_primary_10_3389_fphar_2024_1531288 crossref_primary_10_1007_s00213_016_4214_0 crossref_primary_10_1038_mp_2016_264 crossref_primary_10_1080_15622975_2018_1500033 crossref_primary_10_1016_j_coph_2016_06_007 crossref_primary_10_1186_s12888_022_03747_z crossref_primary_10_46833_reumatologiasp_2017_16_2_30_34 crossref_primary_10_1007_s10545_018_0158_3 crossref_primary_10_1038_s41598_022_15617_5 crossref_primary_10_1038_npp_2016_90 crossref_primary_10_1590_0102_311xpt027423 crossref_primary_10_1017_S0033291715001087 crossref_primary_10_1016_j_jad_2020_09_039 crossref_primary_10_1371_journal_pone_0229273 crossref_primary_10_4103_1673_5374_390964 crossref_primary_10_1016_j_jad_2024_04_019 crossref_primary_10_1016_j_bbii_2024_100100 crossref_primary_10_1007_s11064_021_03274_5 crossref_primary_10_1590_1806_9282_65_3_361 crossref_primary_10_1002_wnan_2021 crossref_primary_10_3390_molecules27031066 crossref_primary_10_1371_journal_pone_0163202 crossref_primary_10_1016_j_ajp_2017_01_025 crossref_primary_10_1016_j_jad_2022_01_024 crossref_primary_10_1016_j_jad_2014_12_015 crossref_primary_10_1186_s40779_024_00577_w crossref_primary_10_1371_journal_pone_0118209 crossref_primary_10_9758_cpn_23_1098 crossref_primary_10_1016_j_bbi_2019_07_020 crossref_primary_10_1016_j_jad_2022_02_025 crossref_primary_10_1176_appi_ajp_2021_21080814 crossref_primary_10_1146_annurev_pharmtox_010617_052823 crossref_primary_10_1016_j_biopsych_2018_07_010 crossref_primary_10_3390_ph14010065 crossref_primary_10_1016_j_rcp_2017_03_002 crossref_primary_10_1016_j_neures_2021_04_001 crossref_primary_10_1016_j_psyneuen_2014_09_031 crossref_primary_10_1055_a_1936_3580 crossref_primary_10_1016_j_physbeh_2015_03_012 crossref_primary_10_3389_fimmu_2016_00140 crossref_primary_10_3390_ijms23116169 crossref_primary_10_1080_08820139_2018_1469649 crossref_primary_10_1017_S0007114521003998 crossref_primary_10_1097_MD_0000000000002401 crossref_primary_10_1016_j_jad_2017_12_099 crossref_primary_10_1016_j_jad_2016_03_057 crossref_primary_10_1159_000448122 crossref_primary_10_1007_s11695_019_03926_0 crossref_primary_10_2174_1570159X17666191108111120 crossref_primary_10_3389_fpsyt_2019_00605 crossref_primary_10_1016_j_bbi_2015_08_004 crossref_primary_10_3390_ijms232213683 crossref_primary_10_1016_j_euroneuro_2019_09_597 crossref_primary_10_1016_j_sjbs_2021_06_007 crossref_primary_10_1016_j_pnpbp_2018_03_012 crossref_primary_10_1016_j_jad_2019_07_045 crossref_primary_10_1155_2015_409637 crossref_primary_10_1016_j_semarthrit_2020_02_001 crossref_primary_10_1016_j_jns_2017_04_017 crossref_primary_10_33667_2078_5631_2019_1_18_393__34_38 crossref_primary_10_1155_2014_360481 crossref_primary_10_1016_j_jpsychores_2016_11_011 crossref_primary_10_1016_j_biopha_2020_111065 crossref_primary_10_1016_j_bbi_2019_12_017 crossref_primary_10_1016_j_jad_2018_11_018 crossref_primary_10_1016_j_jpsychires_2023_06_034 crossref_primary_10_3390_ijerph16224533 crossref_primary_10_1186_s12916_015_0310_y crossref_primary_10_1016_j_jad_2017_10_042 crossref_primary_10_1007_s11920_018_0946_3 crossref_primary_10_1016_j_jad_2021_08_126 crossref_primary_10_1111_ejn_14547 crossref_primary_10_1016_j_neuroscience_2019_02_008 crossref_primary_10_1186_s12888_025_06526_8 crossref_primary_10_1016_j_bbi_2021_09_001 crossref_primary_10_1016_j_ejphar_2018_08_020 crossref_primary_10_1016_j_bbi_2017_08_026 crossref_primary_10_1016_j_rcpeng_2018_05_002 crossref_primary_10_1111_jdv_14175 crossref_primary_10_1016_j_humgen_2023_201233 crossref_primary_10_1016_j_neubiorev_2019_09_025 crossref_primary_10_1186_s12888_018_1900_y crossref_primary_10_1111_cob_12067 crossref_primary_10_1111_bdi_12814 crossref_primary_10_1002_prca_201500149 crossref_primary_10_1016_j_biopha_2018_01_073 crossref_primary_10_1016_j_bbi_2025_02_009 crossref_primary_10_1111_1440_1681_13427 crossref_primary_10_1016_j_nsa_2024_104052 crossref_primary_10_1016_j_jad_2024_01_088 crossref_primary_10_1113_expphysiol_2014_079475 crossref_primary_10_1186_s12974_015_0471_9 crossref_primary_10_3390_plants10102209 crossref_primary_10_1016_j_nsa_2023_103923 crossref_primary_10_1016_j_schres_2014_10_019 crossref_primary_10_1016_j_schres_2022_12_049 crossref_primary_10_1186_s12868_023_00793_5 crossref_primary_10_1007_s12144_021_01396_1 crossref_primary_10_7759_cureus_24765 crossref_primary_10_1111_acps_12414 crossref_primary_10_1111_acps_12656 crossref_primary_10_1177_0269881117711708 crossref_primary_10_1155_2020_2972968 crossref_primary_10_3389_fpsyt_2018_00326 crossref_primary_10_1016_j_plefa_2017_03_003 crossref_primary_10_1016_j_jneuroim_2025_578587 crossref_primary_10_18863_pgy_943148 crossref_primary_10_1007_s00213_019_5175_x crossref_primary_10_1371_journal_pone_0160455 crossref_primary_10_3389_fendo_2016_00010 crossref_primary_10_1016_j_biopha_2024_117802 crossref_primary_10_1111_acps_12791 crossref_primary_10_1080_08039488_2017_1397192 crossref_primary_10_1016_j_pnpbp_2019_03_001 crossref_primary_10_1093_schizbullopen_sgac036 crossref_primary_10_1016_j_euroneuro_2019_09_326 crossref_primary_10_1007_s00520_019_05168_3 crossref_primary_10_1016_j_genhosppsych_2016_04_004 crossref_primary_10_1016_j_intimp_2017_03_002 crossref_primary_10_1159_000501083 crossref_primary_10_1016_j_phrs_2024_107322 crossref_primary_10_2139_ssrn_3963771 crossref_primary_10_1016_j_bbi_2019_03_008 crossref_primary_10_1002_eat_22334 crossref_primary_10_7759_cureus_9708 crossref_primary_10_1016_j_peptides_2015_05_006 crossref_primary_10_1080_15622975_2021_1935317 crossref_primary_10_1177_0269881119841562 crossref_primary_10_1089_cap_2015_0147 crossref_primary_10_1016_j_abrep_2018_03_004 crossref_primary_10_1016_j_imbio_2014_06_003 crossref_primary_10_1016_j_bbih_2024_100781 crossref_primary_10_1016_j_bsheal_2023_04_002 crossref_primary_10_3390_jcm11071974 crossref_primary_10_1016_j_jneuroim_2020_577292 crossref_primary_10_1016_j_neuroscience_2023_12_004 crossref_primary_10_1186_s12974_015_0266_z crossref_primary_10_1016_j_heliyon_2022_e10142 crossref_primary_10_1016_j_trsl_2016_01_003 crossref_primary_10_1016_j_ghres_2024_100004 crossref_primary_10_3389_fnagi_2022_937087 crossref_primary_10_1007_s00702_020_02234_7 crossref_primary_10_3390_healthcare13050441 crossref_primary_10_1016_j_seizure_2016_10_018 crossref_primary_10_1186_s13020_024_00990_2 crossref_primary_10_1155_2019_9165784 crossref_primary_10_3390_ijerph15040771 crossref_primary_10_1016_j_ejphar_2015_12_029 crossref_primary_10_1016_j_psychres_2015_10_029 crossref_primary_10_3390_medicina58020285 crossref_primary_10_1038_npp_2017_231 crossref_primary_10_1016_j_jpsychires_2018_04_004 crossref_primary_10_1017_S0033291717002744 crossref_primary_10_1016_j_pnpbp_2015_04_004 crossref_primary_10_3390_nu14142982 crossref_primary_10_1176_appi_focus_20150040 crossref_primary_10_1016_j_jpsychires_2023_10_036 crossref_primary_10_1093_ijnp_pyx086 crossref_primary_10_1016_j_eurpsy_2019_05_003 crossref_primary_10_1371_journal_pdig_0000204 crossref_primary_10_1016_j_neuroscience_2020_05_014 crossref_primary_10_3389_fnbeh_2014_00099 crossref_primary_10_1016_j_psychres_2017_06_036 crossref_primary_10_36320_ajb_v12_i1_8141 crossref_primary_10_1016_j_pbb_2019_05_009 crossref_primary_10_1016_j_bbih_2022_100472 crossref_primary_10_1016_j_maturitas_2018_12_003 crossref_primary_10_1016_j_bbi_2021_12_020 crossref_primary_10_1016_j_bbi_2016_12_010 crossref_primary_10_2174_1871527319666200726222138 crossref_primary_10_3389_fgene_2023_1242614 crossref_primary_10_1038_s41386_018_0146_1 crossref_primary_10_2174_0929867328666210922160116 crossref_primary_10_3389_fpsyt_2017_00078 crossref_primary_10_1007_s12031_022_02000_2 crossref_primary_10_2174_138161282621200520085710 crossref_primary_10_3389_fpsyt_2022_980315 crossref_primary_10_1038_tp_2014_111 crossref_primary_10_1186_s13148_016_0279_1 crossref_primary_10_1186_s12967_018_1542_3 crossref_primary_10_1007_s40257_017_0279_8 crossref_primary_10_1016_j_jad_2019_02_042 crossref_primary_10_1016_j_jpsychires_2023_03_027 crossref_primary_10_1111_pai_14199 crossref_primary_10_1016_j_jad_2016_12_034 crossref_primary_10_1016_j_joca_2019_12_010 crossref_primary_10_1016_j_jpsychires_2023_03_025 crossref_primary_10_1016_j_jpsychires_2023_03_028 crossref_primary_10_1097_YCO_0000000000000499 crossref_primary_10_1038_s41398_021_01478_5 crossref_primary_10_1111_pcn_13302 crossref_primary_10_1016_j_bbi_2019_02_021 crossref_primary_10_1002_tsm2_50 crossref_primary_10_1016_j_bbi_2021_03_006 crossref_primary_10_1007_s40263_021_00877_y crossref_primary_10_1097_JOM_0000000000003174 crossref_primary_10_1051_ocl_2017007 crossref_primary_10_1016_j_jff_2017_11_003 crossref_primary_10_7717_peerj_12100 crossref_primary_10_3390_life14070887 crossref_primary_10_1007_s11011_023_01189_4 crossref_primary_10_3899_jrheum_2024_0362 crossref_primary_10_1111_1346_8138_16525 crossref_primary_10_1016_j_phrs_2020_105325 crossref_primary_10_1016_j_bbi_2021_03_012 crossref_primary_10_1021_acschemneuro_6b00271 crossref_primary_10_3389_fgene_2019_00098 crossref_primary_10_1017_S1092852918001207 crossref_primary_10_1002_gps_4686 crossref_primary_10_1016_j_neubiorev_2016_02_017 crossref_primary_10_7759_cureus_44584 crossref_primary_10_1111_febs_13358 crossref_primary_10_3390_ijms22147421 crossref_primary_10_1016_j_expneurol_2023_114426 crossref_primary_10_3390_life11080760 crossref_primary_10_1186_s12888_016_1023_2 crossref_primary_10_2478_cpp_2020_0012 crossref_primary_10_1016_j_ajp_2022_103394 crossref_primary_10_1007_s12010_023_04651_2 crossref_primary_10_1038_s41398_020_00920_4 crossref_primary_10_3390_v15061345 crossref_primary_10_4000_pistes_4953 crossref_primary_10_3390_biomedicines10061368 crossref_primary_10_1097_MD_0000000000020981 crossref_primary_10_3390_ijms23020669 crossref_primary_10_1016_j_endmts_2025_100231 crossref_primary_10_1155_2018_9501427 crossref_primary_10_1016_j_psyneuen_2019_104397 crossref_primary_10_1016_j_bbih_2021_100288 crossref_primary_10_1016_j_psc_2015_09_006 crossref_primary_10_1016_j_euroneuro_2014_11_012 crossref_primary_10_1016_j_jad_2022_05_108 crossref_primary_10_1016_j_psc_2015_09_004 crossref_primary_10_2174_1874196702008010029 crossref_primary_10_1007_s13170_014_0078_3 crossref_primary_10_1177_02698811211026426 crossref_primary_10_1016_j_jtumed_2021_02_008 crossref_primary_10_3389_fnins_2023_1214100 crossref_primary_10_1111_pai_14270 crossref_primary_10_1080_08039488_2020_1751878 crossref_primary_10_1038_tp_2016_278 crossref_primary_10_1007_s10067_017_3712_8 crossref_primary_10_31887_DCNS_2017_19_1_rmcintyre crossref_primary_10_1097_PRA_0000000000000135 crossref_primary_10_1016_j_yexmp_2018_08_002 crossref_primary_10_1038_ncomms9885 crossref_primary_10_3389_fnmol_2018_00056 crossref_primary_10_1080_08164622_2022_2145182 crossref_primary_10_2217_pmt_2016_0032 crossref_primary_10_1007_s12160_016_9783_y crossref_primary_10_1016_j_physbeh_2022_113900 crossref_primary_10_1038_mp_2015_92 crossref_primary_10_1016_j_jad_2022_07_020 crossref_primary_10_3389_fnins_2020_00170 crossref_primary_10_3390_ijerph16193524 crossref_primary_10_3389_fnins_2019_00250 crossref_primary_10_1016_j_jneuroim_2018_04_009 crossref_primary_10_3389_fneur_2016_00155 crossref_primary_10_1016_j_jad_2016_06_016 crossref_primary_10_1016_j_psyneuen_2017_01_025 crossref_primary_10_3389_fphar_2023_1107781 crossref_primary_10_1097_SPC_0000000000000229 crossref_primary_10_1093_ageing_afac297 crossref_primary_10_3389_fpsyt_2020_533784 crossref_primary_10_1038_s41398_023_02445_y crossref_primary_10_1093_abm_kay039 crossref_primary_10_2174_0929866527666191223144000 |
| Cites_doi | 10.1136/annrheumdis-2012-201338 10.4088/JCP.v68n1206 10.1038/nrn2297 10.1177/039463200802100208 10.3109/15622975.2011.603223 10.1016/j.jpsychores.2006.09.007 10.1016/S0278-5846(02)00338-X 10.1016/j.jpsychires.2007.05.009 10.1111/j.1399-5618.2007.00493.x 10.1097/00001648-200209000-00012 10.1001/archpsyc.56.5.407 10.1001/archpsyc.58.9.844 10.1017/S1041610212000828 10.1016/j.ejphar.2006.05.047 10.1007/s12325-011-0015-3 10.1007/s00213-012-2671-7 10.1016/j.biopsych.2006.09.033 10.1249/MSS.0b013e3181e3ac80 10.1001/archpsyc.59.10.913 10.1152/japplphysiol.00147.2007 10.1016/j.pnpbp.2007.06.031 10.1016/j.tips.2008.11.002 10.1111/j.1365-2133.2008.08727.x 10.1194/jlr.M002469 10.1016/j.jad.2011.08.022 10.1016/j.psychres.2009.04.013 10.3402/gha.v6i0.18871 10.1111/j.1365-2036.2005.02535.x 10.1016/S0165-0327(00)00252-4 10.1192/bjp.177.5.390 10.1016/S0304-3940(98)00916-1 10.1016/j.pnpbp.2006.05.015 10.1080/00048670701827275 10.1002/hup.912 10.1016/j.bbi.2004.10.003 10.1155/2012/683680 10.1152/ajpendo.00074.2003 10.1159/000336493 10.1016/j.neuroscience.2013.04.060 10.1016/S0049-3848(03)00379-7 10.1111/j.1756-185X.2011.01673.x 10.1038/353164a0 10.4088/JCP.12r07694 10.1001/archpsyc.58.5.445 10.1056/NEJMra1213651 10.1007/s00702-008-0092-x 10.1016/S0197-0186(00)00099-1 10.1001/archgenpsychiatry.2011.60 10.1016/S0140-6736(05)67763-X 10.1016/j.jad.2012.02.016 10.1016/j.nut.2007.10.013 10.1007/s00421-010-1488-5 10.1016/j.bbi.2011.09.015 10.1001/archpsyc.65.9.1017 10.1111/j.1532-5415.2010.02827.x 10.1016/S0197-0186(98)00016-3 10.1002/syn.20905 10.1016/S0002-9149(01)02264-0 10.1176/ajp.153.4.582b 10.1111/j.1365-277X.2012.01283.x 10.1111/j.1749-6632.2009.04984.x 10.1176/ajp.2006.163.9.1561 10.1016/j.jpsychires.2013.06.008 10.1016/S0140-6736(05)61500-0 10.1521/psyc.2006.69.1.1 10.1007/s00228-007-0400-7 10.1056/NEJM200010193431602 10.1586/ern.12.98 10.2500/aap.2013.34.3642 10.1006/brbi.2000.0597 10.1038/ejcn.2008.81 10.1016/S0006-3223(02)01452-X 10.1113/expphysiol.2009.048561 10.2190/PM.41.1.c 10.1016/j.jad.2007.02.018 10.4093/dmj.2013.37.2.106 10.1016/S0893-133X(00)00226-8 10.1176/ajp.146.3.365 10.1016/j.jad.2005.11.015 10.1097/00004850-200607000-00005 10.1177/0269881112458732 10.1016/j.psyneuen.2009.02.004 10.2174/138161209788168001 10.1097/HJR.0b013e3282efaf50 10.3899/jrheum.110900 10.1016/j.plefa.2009.10.007 10.1016/S0306-4530(01)00030-0 10.1016/j.bbi.2003.11.004 10.1007/s00213-006-0582-1 10.1016/S0149-7634(88)80004-6 10.1161/hc1502.107117 10.1017/S1461145702003164 10.1001/jama.295.19.2275 10.1016/j.lfs.2005.12.007 10.1001/archinte.164.9.1010 10.1093/ajcn/54.3.438 10.1002/da.20605 10.1016/j.jacc.2013.07.043 10.1016/j.bbi.2013.04.009 10.1016/S0022-3999(03)00569-5 10.1016/j.bbi.2005.04.003 10.1111/j.1440-1746.2011.07035.x 10.2500/aap.2007.28.2934 10.1016/j.bbi.2012.12.002 10.1016/j.neuro.2012.01.012 10.1111/j.1399-5618.2007.00444.x 10.1001/archpsyc.1983.01790040059008 10.1007/s12640-009-9120-3 10.1007/s00406-007-0797-0 10.1038/sj.mp.4000995 10.1038/sj.mp.4001805 10.1016/j.schres.2007.01.019 10.1001/archgenpsychiatry.2007.11 10.1016/S0006-3223(03)00173-2 10.1097/01.PSY.0000041542.29808.01 10.1371/journal.pone.0028330 10.1001/archpsyc.65.4.395 10.1038/mp.2008.117 10.1177/0269881105058678 10.1210/en.2003-1421 10.1097/YCO.0b013e32835aa4b4 10.1016/S1078-5884(97)80283-3 10.1517/13543784.2013.836487 10.1056/NEJM199906173402407 10.1200/JCO.2000.18.10.2143 10.1007/s00296-010-1616-x 10.1016/j.pnpbp.2007.02.018 10.1161/01.ATV.0000036611.77940.F8 10.1097/JCP.0b013e31823f3b5f 10.1016/j.jad.2008.12.001 10.1016/j.neuroscience.2011.05.023 10.1016/0165-6147(92)90012-U 10.1016/S0893-133X(99)00134-7 10.1002/1529-0131(199912)42:12<2561::AID-ANR8>3.0.CO;2-U 10.1016/j.cellsig.2010.01.010 10.1016/j.pmrj.2010.10.006 10.4088/JCP.v65n0507 10.1038/sj.bjp.0702025 10.1016/j.genhosppsych.2010.07.001 10.1007/BF00435850 10.1016/j.genhosppsych.2012.09.009 10.1016/j.neubiorev.2005.03.023 10.1177/0961203313477227 10.1152/physrev.1999.79.1.1 10.1016/j.pnpbp.2006.09.010 10.1016/j.biocel.2008.06.010 10.1002/ibd.20873 10.1016/j.cca.2010.02.069 10.1002/jbt.10058 10.1016/j.autrev.2012.06.008 10.1002/da.22084 10.1016/j.mehy.2013.02.001 10.1016/j.bbi.2007.03.011 10.1002/da.20589 10.1016/j.plefa.2008.09.016 10.1097/PSY.0b013e3181907c1b 10.1016/j.biopsych.2009.09.033 10.1093/aje/153.3.242 10.1111/j.1365-2133.2007.08205.x 10.1177/070674370104600308 10.3109/03009742.2012.664648 10.1002/hup.390 10.1016/0960-0760(91)90312-S 10.1016/j.phanu.2012.10.004 10.1016/0006-3223(88)90283-1 10.1097/PSY.0b013e3182864ee3 10.1007/s11011-012-9326-6 10.1016/j.bbr.2012.07.026 10.1001/jama.292.14.1724 10.1016/j.bbi.2005.12.002 10.1001/jama.2013.4851 10.3899/jrheum.111068 10.1111/j.1471-4159.2011.07410.x 10.1038/sj.npp.1300022 10.1016/j.bbi.2008.09.007 10.1007/s12160-010-9172-x 10.3109/s10165-012-0643-8 10.1177/070674370705200108 10.1016/0165-0327(95)00028-L 10.1016/j.imbio.2011.01.001 10.1186/1741-7015-11-74 10.1016/S0022-3956(99)00007-2 10.1016/S0006-3223(98)00159-0 10.1176/appi.ajp.160.9.1554 10.1016/j.biopsych.2009.03.015 10.1016/S0165-0327(02)00460-3 10.1089/cap.2011.0009 10.1016/j.jad.2004.01.007 10.1007/s12017-009-8079-9 10.1046/j.1365-2826.2001.00684.x 10.2165/11539700-000000000-00000 10.1001/2013.jamapsychiatry.4 10.1016/j.bbi.2004.05.001 10.1111/bdi.12109 10.1016/0262-1746(83)90048-3 10.1016/j.bbi.2011.03.012 10.1016/j.jad.2011.05.047 10.1002/brb3.72 10.1159/000107420 10.4088/JCP.08r04505 10.1016/j.jad.2012.03.033 10.1016/S0079-6123(02)36037-0 10.1093/ije/dys123 10.1016/j.pnpbp.2012.02.002 10.1007/s11920-012-0313-8 10.1111/j.1755-5949.2011.00259.x 10.1136/bmjopen-2011-000643 10.1176/ajp.147.12.1656 10.1159/000026615 10.3389/fphar.2012.00041 10.1001/archpsyc.61.6.556 10.3390/ijerph8072980 10.1016/j.pnpbp.2010.12.017 10.1186/2047-783X-14-S4-248 10.1503/jpn.100080 10.1111/j.1399-5618.2007.00387.x 10.1097/01.yco.0000228765.33356.9f 10.1016/S0165-0327(01)00377-9 10.1017/S1041610210000864 10.1007/s12017-010-8140-8 10.1016/0022-3956(94)00049-W 10.1016/j.biopsych.2008.11.029 10.1080/08039480802315640 |
| ContentType | Journal Article |
| Copyright | 2014 Elsevier Inc. 2015 INIST-CNRS Copyright © 2014 Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: 2014 Elsevier Inc. – notice: 2015 INIST-CNRS – notice: Copyright © 2014 Elsevier Inc. All rights reserved. |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7TK 7X8 |
| DOI | 10.1016/j.pnpbp.2014.01.013 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Neurosciences Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Neurosciences Abstracts MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1878-4216 |
| EndPage | 34 |
| ExternalDocumentID | 24468642 28559364 10_1016_j_pnpbp_2014_01_013 S0278584614000141 |
| Genre | Journal Article Review |
| GroupedDBID | --- --K --M .~1 0R~ 123 1B1 1RT 1~. 1~5 4.4 457 4G. 5RE 5VS 7-5 71M 8P~ 9JM AABNK AACTN AADPK AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AATCM AAXLA AAXUO ABCQJ ABFRF ABIVO ABJNI ABMAC ABXDB ABYKQ ABZDS ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE AEBSH AEFWE AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGUBO AGWIK AGYEJ AIEXJ AIKHN AITUG AJBFU AJOXV ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC C45 CS3 DU5 EBS EFJIC EFLBG EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA IHE J1W KOM L7B M2V M34 M41 MO0 MOBAO N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SCC SDF SDG SES SSN SSP SSZ T5K TEORI ~G- .GJ 29P 53G AAQXK AATTM AAXKI AAYWO AAYXX ABWVN ACRPL ACVFH ADCNI ADMUD ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRNS AHHHB AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP ASPBG AVWKF AZFZN BNPGV CITATION EJD FEDTE FGOYB G-2 HMQ HMT HVGLF HZ~ R2- SEW SNS SPT SSH WUQ ZGI IQODW CGR CUY CVF ECM EIF NPM 7TK EFKBS 7X8 |
| ID | FETCH-LOGICAL-c488t-f8a2f207dad21fc21e388b07acacf959c7092f5e6dee2b6e746ace6f2f3f7e7f3 |
| IEDL.DBID | .~1 |
| ISSN | 0278-5846 1878-4216 |
| IngestDate | Mon Jul 21 10:38:13 EDT 2025 Tue Aug 05 10:17:03 EDT 2025 Thu Apr 03 07:04:40 EDT 2025 Wed Apr 02 07:21:40 EDT 2025 Tue Jul 01 01:50:17 EDT 2025 Thu Apr 24 23:08:33 EDT 2025 Fri Feb 23 02:24:41 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | CRP BD SSRIs NSAID ACTH Bipolar disorder Non-steroidal anti-inflammatory drug (NSAID) IBD MDD SLE LPS Major depressive disorder ASA IFN IDO CSF PAMPs COX-1 and COX-2 MAOIs TDO WHO AA Mood disorder PGE2 Cytokines TCAs cPLA2 Inflammation O-3 PUFA RA 5-HIAA HPA CRH Drug Interaction Cytokine Depression Review Non steroidal antiinflammatory agent Mood |
| Language | English |
| License | CC BY 4.0 Copyright © 2014 Elsevier Inc. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c488t-f8a2f207dad21fc21e388b07acacf959c7092f5e6dee2b6e746ace6f2f3f7e7f3 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 ObjectType-Review-3 |
| PMID | 24468642 |
| PQID | 1544007346 |
| PQPubID | 23462 |
| PageCount | 12 |
| ParticipantIDs | proquest_miscellaneous_1547537722 proquest_miscellaneous_1544007346 pubmed_primary_24468642 pascalfrancis_primary_28559364 crossref_citationtrail_10_1016_j_pnpbp_2014_01_013 crossref_primary_10_1016_j_pnpbp_2014_01_013 elsevier_sciencedirect_doi_10_1016_j_pnpbp_2014_01_013 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2014-08-04 |
| PublicationDateYYYYMMDD | 2014-08-04 |
| PublicationDate_xml | – month: 08 year: 2014 text: 2014-08-04 day: 04 |
| PublicationDecade | 2010 |
| PublicationPlace | Amsterdam |
| PublicationPlace_xml | – name: Amsterdam – name: England |
| PublicationTitle | Progress in neuro-psychopharmacology & biological psychiatry |
| PublicationTitleAlternate | Prog Neuropsychopharmacol Biol Psychiatry |
| PublicationYear | 2014 |
| Publisher | Elsevier Inc Elsevier |
| Publisher_xml | – name: Elsevier Inc – name: Elsevier |
| References | Wolf (bb1150) 1974; 136 Birerdinc, Afendy, Stepanova, Younossi, Baranova, Younossi (bb0135) 2012; 2 Ahmed, Blair, McIntyre (bb0025) 2011; 28 Quirk, Williams, O'Neil, Pasco, Jacka, Housden (bb0870) 2013; 13 Knijff, Breunis, Kupka, de Wit, Ruwhof, Akkerhuis (bb0510) 2007; 9 Ohishi, Ueno, Nishino, Sakai, Hayaishi (bb0790) 1988; 23 Walker, Graff, Dutz, Bernstein (bb1115) 2011; 88 Goldstein, Kemp, Soczynska, McIntyre (bb0380) 2009; 70 Tsai, Chen, Yang, Chen, Lee, Singh (bb1055) 1999; 45 McIntyre, McCann, Kennedy (bb0660) 2001; 46 Lanquillon, Krieg, Bening-Abu-Shach, Vedder (bb0535) 2000; 22 Jazayeri, Tehrani-Doost, Keshavarz, Hosseini, Djazayery, Amini (bb0445) 2008; 42 Capuron, Ravaud, Miller, Dantzer (bb0205) 2004; 18 Weitz, Town (bb1135) 2012; 2012 Ramasubbu, Taylor, Samaan, Sockalingham, Li, Patten (bb0900) 2012; 24 Orio, Llopis, Torres, Izco, O'Shea, Colado (bb0795) 2010; 18 Stertz, Magalhaes, Kapczinski (bb1000) 2013; 26 Park, Bowers (bb0830) 2010; 22 Abbas, Lichtman, Pillai (bb0005) 2012 De Berardis, Conti, Campanella, Carano, Scali, Valchera (bb0275) 2008; 21 Mahdavian Delavary, van der Veer, van Egmond, Niessen, Beelen (bb0625) 2011; 216 McElroy, Keck (bb0650) 2012; 14 Lee, Rao, Ertley, Chang, Rapoport, Bazinet (bb0545) 2007; 190 Savitz, Preskorn, Teague, Drevets, Yates, Drevets (bb0940) 2012; 2 Bian, Kato, Monji, Hashioka, Mizoguchi, Horikawa (bb0130) 2008; 32 Silverman, Miller, Biron, Pearce (bb0955) 2004; 145 Ertenli, Ozer, Kiraz, Apras, Akdogan, Karadag (bb0305) 2012; 32 Muller (bb0735) 2010; 11 Nilsson, Hellstrand, Ekman, Eriksson (bb0775) 1998; 124 Sookram, Tan, Daya, Heffernan, Mishra (bb0985) 2011; 65 Tisi, Hulse, Chulakadabba, Gosling, Shearman (bb1045) 1997; 14 Tyring, Gottlieb, Papp, Gordon, Leonardi, Wang (bb1075) 2006; 367 Karunakaran, Park (bb0460) 2013; 37 Eyre, Baune (bb0310) 2012; 26 Bongartz, Sutton, Sweeting, Buchan, Matteson, Montori (bb0140) 2006; 295 Gillespie, Phifer, Bradley, Ressler (bb0375) 2009; 26 Church, Barlow, Earnest, Kampert, Priest, Blair (bb0235) 2002; 22 Rapaport, Guylai, Whybrow (bb0905) 1999; 33 Raison, Miller (bb0880) 2013; 31 Capuron, Ravaud, Neveu, Miller, Maes, Dantzer (bb0195) 2002; 7 Capuron, Ravaud, Gualde, Bosmans, Dantzer, Maes (bb0190) 2001; 26 Stewart, Flynn, Campbell, Craig, Robinson, McFarlin (bb1005) 2005; 19 Kenis, Maes (bb0480) 2002; 5 Steptoe, Hamer, Chida (bb0995) 2007; 21 Piomelli, Pilon, Giros, Sokoloff, Martres, Schwartz (bb0855) 1991; 353 Brietzke, Stertz, Fernandes, Kauer-Sant'anna, Mascarenhas, Escosteguy Vargas (bb0155) 2009; 116 Wilczynska-Kwiatek, Bargiel-Matusiewicz, Lapinski (bb1145) 2009; 14 Wright, Strike, Brydon, Steptoe (bb1165) 2005; 19 Zhang, Shirayama, Shimizu, Iyo, Hashimoto (bb1190) 2006; 544 Clayton, Hanstock, Hirneth, Kable, Garg, Hazell (bb0240) 2009; 63 Hoes, Sijben (bb0425) 1981; 75 Huang, Lin (bb0440) 2007; 31 Kempton, Salvador, Munafo, Geddes, Simmons, Frangou (bb0475) 2011; 68 Rosa-Neto, Diksic, Okazawa, Leyton, Ghadirian, Mzengeza (bb0920) 2004; 61 Nishino, Ueno, Ohishi, Sakai, Hayaishi (bb0780) 1989; 146 Pedersen, Pedersen, Krabbe, Bruunsgaard, Matthews, Febbraio (bb0835) 2009; 94 Breunis, Kupka, Nolen, Suppes, Denicoff, Leverich (bb0150) 2003; 53 Frol, Vasquez, Getahun, Pacheco, Khan, Brown (bb0350) 2013; 34 Porterfield, Zimomra, Caldwell, Camp, Gabella, Johnson (bb0860) 2011; 188 Qu, Chang, Klaff, Balbo, Rapoport (bb0865) 2003; 28 Rothon, Edwards, Bhui, Viner, Taylor, Stansfeld (bb0925) 2010; 8 Krishnan, Cella, Leonardi, Papp, Gottlieb, Dunn (bb0530) 2007; 157 Morriss, Mohammed (bb0725) 2005; 19 Barton, Esler, Dawood, Lambert, Haikerwal, Brenchley (bb0085) 2008; 65 Ahmed, Warton, Schaefer, Shen, McIntyre (bb0030) 2013 Fischer (bb0330) 2006; 12 Kohut, McCann, Russell, Konopka, Cunnick, Franke (bb0515) 2006; 20 Almeida, Alfonso, Jamrozik, Hankey, Flicker (bb0050) 2010; 58 Maheshwari, Singh, Gaddipati, Srimal (bb0630) 2006; 78 Grigoleit, Kullmann, Wolf, Hammes, Wegner, Jablonowski (bb0395) 2011; 6 Padmos, Hillegers, Knijff, Vonk, Bouvy, Staal (bb0815) 2008; 65 Chen, Epstein, Stern (bb0225) 2010; 2 Lopez-Munoz, Alamo (bb0590) 2009; 15 Capuron, Neurauter, Musselman, Lawson, Nemeroff, Fuchs (bb0200) 2003; 54 Ghattas, Griffiths, Devitt, Lip, Shantsila (bb0370) 2013; 62 Conn (bb0245) 2010; 39 Zhang, Kitaichi, Fujimoto, Nakayama, Shimizu, Iyo (bb1185) 2006; 30 Mead, Morley, Campbell, Greig, McMurdo, Lawlor (bb0690) 2009; 3 Loerbroks, Herr, Subramanian, Bosch (bb0585) 2012; 41 Pace, Miller (bb0810) 2009; 1179 Grinevich, Ma, Herman, Jezova, Akmayev, Aguilera (bb0400) 2001; 13 Peet, Horrobin (bb0840) 2002; 59 Mok, Lok, Cheung (bb0720) 2012; 41 Brydon, Walker, Wawrzyniak, Whitehead, Okamura, Yajima (bb0170) 2009; 23 Liu, Ho, Mak (bb0580) 2012; 15 Murphy (bb0745) 1991; 38 Calder (bb0180) 2008; 79 Dantzer, O'Connor, Freund, Johnson, Kelley (bb0270) 2008; 9 Tsai, Chung, Wu, Kuo, Lee, Huang (bb1065) 2012; 136 Lopresti, Hood, Drummond (bb0595) 2012; 26 Tran, Oliver, Rosa, Galassetti (bb1050) 2012; 2012 Danner, Kasl, Abramson, Vaccarino (bb0265) 2003; 65 Paradise, Naismith, Norrie, Graeber, Hickie (bb0825) 2012; 24 Harry, Kraft (bb0415) 2012; 33 Stolk, Souverein, Wilting, Leufkens, Klein, Rapoport (bb1010) 2010; 82 Maes, Leonard, Myint, Kubera, Verkerk (bb0610) 2011; 35 Cooney, Dwan, Greig, Lawlor, Rimer, Waugh (bb0250) 2013; 12 Murakami, Mizoue, Sasaki, Ohta, Sato, Matsushita (bb0740) 2008; 24 Dowlati, Herrmann, Swardfager, Liu, Sham, Reim (bb0285) 2010; 67 Vane, Botting (bb1095) 2003; 110 Simopoulos (bb0960) 1991; 54 Alsuwaidan, Kucyi, Law, McIntyre (bb0055) 2009; 11 Boufidou, Nikolaou, Alevizos, Liappas, Christodoulou (bb0145) 2004; 82 Kadoglou, Iliadis, Angelopoulou, Perrea, Ampatzidis, Liapis (bb0455) 2007; 14 Shi, Klotz (bb0950) 2008; 64 Jazayeri, Keshavarz, Tehrani-Doost, Djalali, Hosseini, Amini (bb0450) 2010; 178 Myint, Steinbusch, Goeghegan, Luchtman, Kim, Leonard (bb0755) 2007; 14 Aggarwal, Sung (bb0020) 2009; 30 McNamara, Nandagopal, Strakowski, DelBello (bb0665) 2010; 24 Vaswani, Linda, Ramesh (bb1100) 2003; 27 Levine, Cholestoy, Zimmerman (bb0555) 1996; 153 Nicassio, Ormseth, Custodio, Irwin, Olmstead, Weisman (bb0770) 2012; 39 Muller, Schwarz, Dehning, Douhe, Cerovecki, Goldstein-Muller (bb0730) 2006; 11 Maritim, Sanders, Watkins (bb0635) 2003; 17 Beishuizen, Thijs (bb0110) 2003; 9 Kim, Jung, Myint, Kim, Park (bb0500) 2007; 104 Kempton, Geddes, Ettinger, Williams, Grasby (bb0470) 2008; 65 Akhondzadeh, Jafari, Raisi, Nasehi, Ghoreishi, Salehi (bb0040) 2009; 26 Graff, Walker, Bernstein (bb0390) 2009; 15 Yirmiya, Pollak, Barak, Avitsur, Ovadia, Bette (bb1175) 2001; 24 Sloan, Shapiro, Demeersman, McKinley, Tracey, Slavov (bb0965) 2007; 103 Sanhueza, Ryan, Foxcroft (bb0930) 2013; 26 Kato, Monji, Hashioka, Kanba (bb0465) 2007; 92 Levine, Barak, Chengappa, Rapoport, Rebey, Barak (bb0550) 1999; 40 Raison, Broadwell, Borisov, Manatunga, Capuron, Woolwine (bb0875) 2005; 19 Chen, Tzeng, Chen (bb0220) 2010; 32 Nathan (bb0760) 2007; 28 Brietzke, Mansur, Soczynska, Kapczinski, Bressan, McIntyre (bb0160) 2012; 140 Musil, Schwarz, Riedel, Dehning, Cerovecki, Spellmann (bb0750) 2011; 134 Kim, Cheon, Modi, Rapoport, Rao (bb0495) 2012; 222 Raju (bb0895) 1998; 352 Baldwin (bb0080) 2010; 22 Ekdahl (bb0295) 2012; 3 O'Brien, Scully, Scott, Dinan (bb0785) 2006; 90 Strohle (bb1025) 2009; 116 Kling, Alesci, Csako, Costello, Luckenbaugh, Bonne (bb0505) 2007; 62 Maggard-Gibbons, Maglione, Livhits, Ewing, Maher, Hu (bb0620) 2013; 309 Kraft, Harry (bb0525) 2011; 8 Cunha, Andreazza, Gomes, Frey, da Silveira, Goncalves (bb0260) 2008; 258 Kent, Bluthe, Kelley, Dantzer (bb0485) 1992; 13 McElroy, Kotwal, Malhotra, Nelson, Keck, Nemeroff (bb0655) 2004; 65 Linnoila, Whorton, Rubinow, Cowdry, Ninan, Waters (bb0575) 1983; 40 Feldman, Gottlieb, Bala, Wu, Eisenberg, Guzzo (bb0315) 2008; 159 Capuron, Ravaud, Dantzer (bb0185) 2000; 18 Kessler, Akiskal, Ames, Birnbaum, Greenberg, Hirschfeld (bb0490) 2006; 163 McNamara, Strawn (bb0675) 2013; 1 Peltzer, Phaswana-Mafuya (bb0845) 2013; 6 Soderlund, Olsson, Samuelsson, Walther-Jallow, Johansson, Erhardt (bb0980) 2011; 36 Palagini, Mosca, Tani, Gemignani, Mauri, Bombardieri (bb0820) 2013; 22 Alavi, Grebely, Matthews, Petoumenos, Yeung, Day (bb0045) 2012; 27 Tsai, Yang, Kuo, Chen, Leu (bb1060) 2001; 64 Berger, Proffitt, McConchie, Yuen, Wood, Amminger (bb0115) 2007; 68 Persoons, Vermeire, Demyttenaere, Fischler, Vandenberghe, Van Oudenhove (bb0850) 2005; 22 World Health Organization (WHO) (bb1160) 2012 Miller, Maletic, Raison (bb0705) 2009; 65 Berlim, Turecki (bb0125) 2007; 52 Osby, Brandt, Correia, Ekbom, Sparen (bb0805) 2001; 58 Stoll, Severus, Freeman, Rueter, Zboyan, Diamond (bb1015) 1999; 56 McNamara, Lotrich (bb0670) 2012; 12 Fountoulakis (bb0345) 2012; 18 Ford (bb0340) 2002; 13 Hart (bb0420) 1988; 12 Lee, Rao, Chang, Rapoport, Kim (bb0540) 2010; 15 Zhang, Terreni, De Simoni, Dunn (bb1180) 2001; 38 Raison, Miller (bb0885) 2003; 160 Cheon, Park, Modi, Kim, Lee, Chang (bb0230) 2011; 119 McQuade, Young (bb0685) 2000; 177 Sublette, Bosetti, DeMar, Ma, Bell, Fagin-Jones (bb1040) 2007; 9 Dickerson, Stallings, Origoni, Boronow, Yolken (bb0280) 2007; 31 Soczynska, Kennedy, Woldeyohannes, Liauw, Alsuwaidan, Yim (bb0970) 2011; 13 Zorrilla, Luborsky, McKay, Rosenthal, Houldin, Tax (bb1195) 2001; 15 Beavers, Hsu, Isom, Kritchevsky, Church, Goodpaster (bb0105) 2010; 42 Anders, Tanaka, Kinney (bb0060) 2013; 31 Ortiz-Dominguez, Hernandez, Berlanga, Gutierrez-Mora, Moreno, Heinze (bb0800) 2007; 9 Wadee, Kuschke, Wood, Berk, Ichim, Maes (bb1105) 2002; 17 Atzeni, Sarzi-Puttini, Botsios, Carletto, Cipriani, Favalli (bb0075) 2012; 12 Geffken, Cushman, Burke, Polak, Sakkinen, Tracy (bb0360) 2001; 153 Raison, Rutherford, Woolwine, Shuo, Schettler, Drake (bb0890) 2013; 70 van Dartel, Fransen, Kievit, Flendrie, den Broeder, Visser (bb1085) 2013; 72 Lindahl, Toss, Siegbahn, Venge, Wallentin (bb0570) 2000; 343 Baune, Thome (bb0095) 2011; 12 Angst, Stassen, Clayton, Angst (bb0065) 2002; 68 Maes, Meltzer, Bosmans, Bergmans, Vandoolaeghe, Ranjan (bb0605) 1995; 34 Funk, Gohlke, Kraft, McPherson, Collins, Jean (bb0355) 2011; 25 Martinsen (bb0645) 2008; 62 Reichenberg, Yirmiya, Schuld, Kraus, Haack, Morag (bb0915) 2001; 58 Turnbul Barton (10.1016/j.pnpbp.2014.01.013_bb0085) 2008; 65 Kessler (10.1016/j.pnpbp.2014.01.013_bb0490) 2006; 163 Sloan (10.1016/j.pnpbp.2014.01.013_bb0965) 2007; 103 Sookram (10.1016/j.pnpbp.2014.01.013_bb0985) 2011; 65 Stertz (10.1016/j.pnpbp.2014.01.013_bb1000) 2013; 26 Capuron (10.1016/j.pnpbp.2014.01.013_bb0190) 2001; 26 Funk (10.1016/j.pnpbp.2014.01.013_bb0355) 2011; 25 Maheshwari (10.1016/j.pnpbp.2014.01.013_bb0630) 2006; 78 Sharma (10.1016/j.pnpbp.2014.01.013_bb0945) 2013; 35 Raju (10.1016/j.pnpbp.2014.01.013_bb0895) 1998; 352 Rees (10.1016/j.pnpbp.2014.01.013_bb0910) 2010; 13 Zorrilla (10.1016/j.pnpbp.2014.01.013_bb1195) 2001; 15 McNamara (10.1016/j.pnpbp.2014.01.013_bb0675) 2013; 1 Wright (10.1016/j.pnpbp.2014.01.013_bb1165) 2005; 19 Muller (10.1016/j.pnpbp.2014.01.013_bb0735) 2010; 11 Covic (10.1016/j.pnpbp.2014.01.013_bb0255) 2012; 12 Carpenter (10.1016/j.pnpbp.2014.01.013_bb0215) 2004; 79 Udina (10.1016/j.pnpbp.2014.01.013_bb1080) 2012; 73 Ekdahl (10.1016/j.pnpbp.2014.01.013_bb0295) 2012; 3 Van Lieshout (10.1016/j.pnpbp.2014.01.013_bb1090) 2012; 98 Maes (10.1016/j.pnpbp.2014.01.013_bb0615) 2012; 27 Arango (10.1016/j.pnpbp.2014.01.013_bb0070) 2002; 136 Stubner (10.1016/j.pnpbp.2014.01.013_bb1030) 1999; 259 Beavers (10.1016/j.pnpbp.2014.01.013_bb0100) 2010; 411 Rosa-Neto (10.1016/j.pnpbp.2014.01.013_bb0920) 2004; 61 Alsuwaidan (10.1016/j.pnpbp.2014.01.013_bb0055) 2009; 11 Cooney (10.1016/j.pnpbp.2014.01.013_bb0250) 2013; 12 Padmos (10.1016/j.pnpbp.2014.01.013_bb0815) 2008; 65 Baune (10.1016/j.pnpbp.2014.01.013_bb0095) 2011; 12 Peltzer (10.1016/j.pnpbp.2014.01.013_bb0845) 2013; 6 Wilczynska-Kwiatek (10.1016/j.pnpbp.2014.01.013_bb1145) 2009; 14 Kent (10.1016/j.pnpbp.2014.01.013_bb0485) 1992; 13 Murakami (10.1016/j.pnpbp.2014.01.013_bb0740) 2008; 24 Nishino (10.1016/j.pnpbp.2014.01.013_bb0780) 1989; 146 Rothon (10.1016/j.pnpbp.2014.01.013_bb0925) 2010; 8 Harrison (10.1016/j.pnpbp.2014.01.013_bb0410) 2009; 66 Mahdavian Delavary (10.1016/j.pnpbp.2014.01.013_bb0625) 2011; 216 Kohut (10.1016/j.pnpbp.2014.01.013_bb0515) 2006; 20 Martins (10.1016/j.pnpbp.2014.01.013_bb0640) 2010; 110 Porterfield (10.1016/j.pnpbp.2014.01.013_bb0860) 2011; 188 Liang (10.1016/j.pnpbp.2014.01.013_bb0560) 2013; 368 Vane (10.1016/j.pnpbp.2014.01.013_bb1095) 2003; 110 Dunn (10.1016/j.pnpbp.2014.01.013_bb0290) 2005; 29 Hoes (10.1016/j.pnpbp.2014.01.013_bb0425) 1981; 75 Mendlewicz (10.1016/j.pnpbp.2014.01.013_bb0700) 2006; 21 Tran (10.1016/j.pnpbp.2014.01.013_bb1050) 2012; 2012 Jazayeri (10.1016/j.pnpbp.2014.01.013_bb0445) 2008; 42 Raison (10.1016/j.pnpbp.2014.01.013_bb0890) 2013; 70 Danner (10.1016/j.pnpbp.2014.01.013_bb0265) 2003; 65 Pedersen (10.1016/j.pnpbp.2014.01.013_bb0835) 2009; 94 Kenis (10.1016/j.pnpbp.2014.01.013_bb0480) 2002; 5 Wannamethee (10.1016/j.pnpbp.2014.01.013_bb1125) 2002; 105 Angst (10.1016/j.pnpbp.2014.01.013_bb0065) 2002; 68 Capuron (10.1016/j.pnpbp.2014.01.013_bb0185) 2000; 18 Atzeni (10.1016/j.pnpbp.2014.01.013_bb0075) 2012; 12 Su (10.1016/j.pnpbp.2014.01.013_bb1035) 2013; 22 Piomelli (10.1016/j.pnpbp.2014.01.013_bb0855) 1991; 353 Breunis (10.1016/j.pnpbp.2014.01.013_bb0150) 2003; 53 Ghattas (10.1016/j.pnpbp.2014.01.013_bb0370) 2013; 62 Berger (10.1016/j.pnpbp.2014.01.013_bb0115) 2007; 68 Ramasubbu (10.1016/j.pnpbp.2014.01.013_bb0900) 2012; 24 Ahmed (10.1016/j.pnpbp.2014.01.013_bb0030) 2013 van Dartel (10.1016/j.pnpbp.2014.01.013_bb1085) 2013; 72 Kim (10.1016/j.pnpbp.2014.01.013_bb0500) 2007; 104 Brietzke (10.1016/j.pnpbp.2014.01.013_bb0155) 2009; 116 Gillespie (10.1016/j.pnpbp.2014.01.013_bb0375) 2009; 26 Krishnan (10.1016/j.pnpbp.2014.01.013_bb0530) 2007; 157 Lieb (10.1016/j.pnpbp.2014.01.013_bb0565) 1983; 10 Berk (10.1016/j.pnpbp.2014.01.013_bb0120) 2013; 11 Muller (10.1016/j.pnpbp.2014.01.013_bb0730) 2006; 11 Maes (10.1016/j.pnpbp.2014.01.013_bb0605) 1995; 34 Kempton (10.1016/j.pnpbp.2014.01.013_bb0470) 2008; 65 Sublette (10.1016/j.pnpbp.2014.01.013_bb1040) 2007; 9 Weigle (10.1016/j.pnpbp.2014.01.013_bb1130) 2013; 87 McNamara (10.1016/j.pnpbp.2014.01.013_bb0665) 2010; 24 Aggarwal (10.1016/j.pnpbp.2014.01.013_bb0020) 2009; 30 Ahmedani (10.1016/j.pnpbp.2014.01.013_bb0035) 2013; 75 Zhang (10.1016/j.pnpbp.2014.01.013_bb1190) 2006; 544 O'Brien (10.1016/j.pnpbp.2014.01.013_bb0785) 2006; 90 Wolfe (10.1016/j.pnpbp.2014.01.013_bb1155) 1999; 340 Zhang (10.1016/j.pnpbp.2014.01.013_bb1185) 2006; 30 McNamara (10.1016/j.pnpbp.2014.01.013_bb0670) 2012; 12 Ohishi (10.1016/j.pnpbp.2014.01.013_bb0790) 1988; 23 Goldstein (10.1016/j.pnpbp.2014.01.013_bb0380) 2009; 70 Soczynska (10.1016/j.pnpbp.2014.01.013_bb0975) 2012; 235 McNamara (10.1016/j.pnpbp.2014.01.013_bb0680) 2008; 42 Palagini (10.1016/j.pnpbp.2014.01.013_bb0820) 2013; 22 Brietzke (10.1016/j.pnpbp.2014.01.013_bb0160) 2012; 140 Kling (10.1016/j.pnpbp.2014.01.013_bb0505) 2007; 62 McElroy (10.1016/j.pnpbp.2014.01.013_bb0655) 2004; 65 Paradise (10.1016/j.pnpbp.2014.01.013_bb0825) 2012; 24 Ertenli (10.1016/j.pnpbp.2014.01.013_bb0305) 2012; 32 Jazayeri (10.1016/j.pnpbp.2014.01.013_bb0450) 2010; 178 Murphy (10.1016/j.pnpbp.2014.01.013_bb0745) 1991; 38 Lanquillon (10.1016/j.pnpbp.2014.01.013_bb0535) 2000; 22 Dickerson (10.1016/j.pnpbp.2014.01.013_bb0280) 2007; 31 Felger (10.1016/j.pnpbp.2014.01.013_bb0320) 2013; 246 Lopez-Munoz (10.1016/j.pnpbp.2014.01.013_bb0590) 2009; 15 Sato (10.1016/j.pnpbp.2014.01.013_bb0935) 2013; 23 Boufidou (10.1016/j.pnpbp.2014.01.013_bb0145) 2004; 82 Hart (10.1016/j.pnpbp.2014.01.013_bb0420) 1988; 12 Weitz (10.1016/j.pnpbp.2014.01.013_bb1135) 2012; 2012 Harry (10.1016/j.pnpbp.2014.01.013_bb0415) 2012; 33 Stolk (10.1016/j.pnpbp.2014.01.013_bb1010) 2010; 82 Miyaoka (10.1016/j.pnpbp.2014.01.013_bb0715) 2012; 37 Huang (10.1016/j.pnpbp.2014.01.013_bb0440) 2007; 31 Howren (10.1016/j.pnpbp.2014.01.013_bb0435) 2009; 71 Pace (10.1016/j.pnpbp.2014.01.013_bb0810) 2009; 1179 Hough (10.1016/j.pnpbp.2014.01.013_bb0430) 2006; 69 Dantzer (10.1016/j.pnpbp.2014.01.013_bb0270) 2008; 9 Nathan (10.1016/j.pnpbp.2014.01.013_bb0760) 2007; 28 World Health Organization (WHO) (10.1016/j.pnpbp.2014.01.013_bb1160) Mead (10.1016/j.pnpbp.2014.01.013_bb0690) 2009; 3 Carek (10.1016/j.pnpbp.2014.01.013_bb0210) 2011; 41 Cunha (10.1016/j.pnpbp.2014.01.013_bb0260) 2008; 258 Kempton (10.1016/j.pnpbp.2014.01.013_bb0475) 2011; 68 Nilsson (10.1016/j.pnpbp.2014.01.013_bb0775) 1998; 124 Capuron (10.1016/j.pnpbp.2014.01.013_bb0200) 2003; 54 Loerbroks (10.1016/j.pnpbp.2014.01.013_bb0585) 2012; 41 Tsai (10.1016/j.pnpbp.2014.01.013_bb1060) 2001; 64 Bian (10.1016/j.pnpbp.2014.01.013_bb0130) 2008; 32 Martinsen (10.1016/j.pnpbp.2014.01.013_bb0645) 2008; 62 Nery (10.1016/j.pnpbp.2014.01.013_bb0765) 2008; 23 Karunakaran (10.1016/j.pnpbp.2014.01.013_bb0460) 2013; 37 Kim (10.1016/j.pnpbp.2014.01.013_bb0495) 2012; 222 Shi (10.1016/j.pnpbp.2014.01.013_bb0950) 2008; 64 Walker (10.1016/j.pnpbp.2014.01.013_bb1115) 2011; 88 Savitz (10.1016/j.pnpbp.2014.01.013_bb0940) 2012; 2 Hamer (10.1016/j.pnpbp.2014.01.013_bb0405) 2009; 34 Levine (10.1016/j.pnpbp.2014.01.013_bb0550) 1999; 40 Ford (10.1016/j.pnpbp.2014.01.013_bb0335) 2004; 164 Strike (10.1016/j.pnpbp.2014.01.013_bb1020) 2004; 57 Clayton (10.1016/j.pnpbp.2014.01.013_bb0240) 2009; 63 Maes (10.1016/j.pnpbp.2014.01.013_bb0600) 1995; 29 Mello (10.1016/j.pnpbp.2014.01.013_bb0695) 2013; 47 Cheon (10.1016/j.pnpbp.2014.01.013_bb0230) 2011; 119 Soderlund (10.1016/j.pnpbp.2014.01.013_bb0980) 2011; 36 Akhondzadeh (10.1016/j.pnpbp.2014.01.013_bb0040) 2009; 26 Capuron (10.1016/j.pnpbp.2014.01.013_bb0195) 2002; 7 Levine (10.1016/j.pnpbp.2014.01.013_bb0555) 1996; 153 Zhang (10.1016/j.pnpbp.2014.01.013_bb1180) 2001; 38 Linnoila (10.1016/j.pnpbp.2014.01.013_bb0575) 1983; 40 Raison (10.1016/j.pnpbp.2014.01.013_bb0875) 2005; 19 McQuade (10.1016/j.pnpbp.2014.01.013_bb0685) 2000; 177 Beavers (10.1016/j.pnpbp.2014.01.013_bb0105) 2010; 42 Fountoulakis (10.1016/j.pnpbp.2014.01.013_bb0345) 2012; 18 Wolf (10.1016/j.pnpbp.2014.01.013_bb1150) 1974; 136 Lee (10.1016/j.pnpbp.2014.01.013_bb0545) 2007; 190 Grigoleit (10.1016/j.pnpbp.2014.01.013_bb0395) 2011; 6 Kato (10.1016/j.pnpbp.2014.01.013_bb0465) 2007; 92 Dowlati (10.1016/j.pnpbp.2014.01.013_bb0285) 2010; 67 Almeida (10.1016/j.pnpbp.2014.01.013_bb0050) 2010; 58 Lindahl (10.1016/j.pnpbp.2014.01.013_bb0570) 2000; 343 Wadee (10.1016/j.pnpbp.2014.01.013_bb1105) 2002; 17 Ortiz-Dominguez (10.1016/j.pnpbp.2014.01.013_bb0800) 2007; 9 Frol (10.1016/j.pnpbp.2014.01.013_bb0350) 2013; 34 Graff (10.1016/j.pnpbp.2014.01.013_bb0390) 2009; 15 Brydon (10.1016/j.pnpbp.2014.01.013_bb0170) 2009; 23 Persoons (10.1016/j.pnpbp.2014.01.013_bb0850) 2005; 22 McElroy (10.1016/j.pnpbp.2014.01.013_bb0650) 2012; 14 Aggarwal (10.1016/j.pnpbp.2014.01.013_bb0015) 2009; 41 Lopresti (10.1016/j.pnpbp.2014.01.013_bb0595) 2012; 26 Alavi (10.1016/j.pnpbp.2014.01.013_bb0045) 2012; 27 Goldstein (10.1016/j.pnpbp.2014.01.013_bb0385) 2011; 21 Mok (10.1016/j.pnpbp.2014.01.013_bb0720) 2012; 41 Strohle (10.1016/j.pnpbp.2014.01.013_bb1025) 2009; 116 Maggard-Gibbons (10.1016/j.pnpbp.2014.01.013_bb0620) 2013; 309 Raison (10.1016/j.pnpbp.2014.01.013_bb0885) 2003; 160 Lee (10.1016/j.pnpbp.2014.01.013_bb0540) 2010; 15 Nicassio (10.1016/j.pnpbp.2014.01.013_bb0770) 2012; 39 Birerdinc (10.1016/j.pnpbp.2014.01.013_bb0135) 2012; 2 Bongartz (10.1016/j.pnpbp.2014.01.013_bb0140) 2006; 295 Eyre (10.1016/j.pnpbp.2014.01.013_bb0310) 2012; 26 Orio (10.1016/j.pnpbp.2014.01.013_bb0795) 2010; 18 Tyring (10.1016/j.pnpbp.2014.01.013_bb1075) 2006; 367 Silverman (10.1016/j.pnpbp.2014.01.013_bb0955) 2004; 145 Steensberg (10.1016/j.pnpbp.2014.01.013_bb0990) 2003; 285 Kadoglou (10.1016/j.pnpbp.2014.01.013_bb0455) 2007; 14 Maes (10.1016/j.pnpbp.2014.01.013_bb0610) 2011; 35 Qu (10.1016/j.pnpbp.2014.01.013_bb0865) 2003; 28 Musil (10.1016/j.pnpbp.2014.01.013_bb0750) 2011; 134 Kraft (10.1016/j.pnpbp.2014.01.013_bb0525) 2011; 8 Vaswani (10.1016/j.pnpbp.2014.01.013_bb1100) 2003; 27 Brietzke (10.1016/j.pnpbp.2014.01.013_bb0165) 2013; 80 Ahmed (10.1016/j.pnpbp.2014.01.013_bb0025) 2011; 28 McIntyre (10.1016/j.pnpbp.2014.01.013_bb0660) 2001; 46 Gertsik (10.1016/j.pnpbp.2014.01.013_bb0365) 2012; 32 Sanhueza (10.1016/j.pnpbp.2014.01.013_bb0930) 2013; 26 Beishuizen (10.1016/j.pnpbp.2014.01.013_bb0110) 2003; |
| References_xml | – volume: 11 start-page: 680 year: 2006 end-page: 684 ident: bb0730 article-title: The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine publication-title: Mol Psychiatry – volume: 75 start-page: 346 year: 1981 end-page: 349 ident: bb0425 article-title: The clinical significance of disordered renal excretion of xanthurenic acid in depressive patients publication-title: Psychopharmacology (Berl) – volume: 62 start-page: 207 year: 2007 end-page: 214 ident: bb1140 article-title: Interferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisol publication-title: J Psychosom Res – volume: 8 year: 2010 ident: bb0925 article-title: Physical activity and depressive symptoms in adolescents: a prospective study publication-title: BMC Med – volume: 140 start-page: 82 year: 2012 end-page: 91 ident: bb0160 article-title: Towards a multifactorial approach for prediction of bipolar disorder in at risk populations publication-title: J Affect Disord – volume: 41 start-page: 40 year: 2009 end-page: 59 ident: bb0015 article-title: Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases publication-title: Int J Biochem Cell Biol – volume: 92 start-page: 108 year: 2007 end-page: 115 ident: bb0465 article-title: Risperidone significantly inhibits interferon-gamma-induced microglial activation in vitro publication-title: Schizophr Res – volume: 14 start-page: 344 year: 1997 end-page: 350 ident: bb1045 article-title: Exercise training for intermittent claudication: does it adversely affect biochemical markers of the exercise-induced inflammatory response? publication-title: Eur J Vasc Endovasc Surg – volume: 19 start-page: 23 year: 2005 end-page: 27 ident: bb0875 article-title: Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C publication-title: Brain Behav Immun – volume: 14 start-page: 837 year: 2007 end-page: 843 ident: bb0455 article-title: The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus publication-title: Eur J Cardiovasc Prev Rehabil – volume: 18 start-page: 2143 year: 2000 end-page: 2151 ident: bb0185 article-title: Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy publication-title: J Clin Oncol – volume: 12 start-page: CD004366 year: 2013 ident: bb0250 article-title: Exercise for depression publication-title: Cochrane Database Syst Rev – volume: 222 start-page: 663 year: 2012 end-page: 674 ident: bb0495 article-title: Effects of chronic clozapine administration on markers of arachidonic acid cascade and synaptic integrity in rat brain publication-title: Psychopharmacology (Berl) – volume: 42 start-page: 192 year: 2008 end-page: 198 ident: bb0445 article-title: Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder publication-title: Aust N Z J Psychiatry – volume: 75 start-page: 305 year: 2013 end-page: 310 ident: bb0035 article-title: Examining the relationship between depression and asthma exacerbations in a prospective follow-up study publication-title: Psychosom Med – volume: 72 start-page: 895 year: 2013 end-page: 900 ident: bb1085 article-title: Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch rheumatoid arthritis monitoring (DREAM) registry publication-title: Ann Rheum Dis – volume: 65 start-page: 788 year: 2011 end-page: 794 ident: bb0985 article-title: Curcumin prevents haloperidol-induced development of abnormal oro-facial movements: possible implications of bcl-XL in its mechanism of action publication-title: Synapse – volume: 124 start-page: 1651 year: 1998 end-page: 1658 ident: bb0775 article-title: Direct dopamine D2-receptor-mediated modulation of arachidonic acid release in transfected CHO cells without the concomitant administration of a Ca2 publication-title: Br J Pharmacol – volume: 62 start-page: 25 year: 2008 end-page: 29 ident: bb0645 article-title: Physical activity in the prevention and treatment of anxiety and depression publication-title: Nord J Psychiatry – volume: 13 start-page: 561 year: 2002 end-page: 568 ident: bb0340 article-title: Does exercise reduce inflammation? Pysical activity and C-reactive protein among U.S. adults publication-title: Epidemiology – volume: 19 start-page: 389 year: 2005 end-page: 397 ident: bb1005 article-title: Influence of exercise training and age on CD14 publication-title: Brain Behav Immun – volume: 65 start-page: 347 year: 2003 end-page: 356 ident: bb0265 article-title: Association between depression and elevated C-reactive protein publication-title: Psychosom Med – volume: 56 start-page: 407 year: 1999 end-page: 412 ident: bb1015 article-title: Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial publication-title: Arch Gen Psychiatry – volume: 411 start-page: 785 year: 2010 end-page: 793 ident: bb0100 article-title: Effect of exercise training on chronic inflammation publication-title: Clin Chim Acta – volume: 42 start-page: 2189 year: 2010 end-page: 2196 ident: bb0105 article-title: Long-term physical activity and inflammatory biomarkers in older adults publication-title: Med Sci Sports Exerc – volume: 19 start-page: 345 year: 2005 end-page: 350 ident: bb1165 article-title: Acute inflammation and negative mood: mediation by cytokine activation publication-title: Brain Behav Immun – volume: 20 start-page: 201 year: 2006 end-page: 209 ident: bb0515 article-title: Aerobic exercise, but not flexibility/resistance exercise, reduces serum IL-18, CRP, and IL-6 independent of beta-blockers, BMI, and psychosocial factors in older adults publication-title: Brain Behav Immun – volume: 8 start-page: 2980 year: 2011 end-page: 3018 ident: bb0525 article-title: Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity publication-title: Int J Environ Res Public Health – volume: 2012 start-page: 314185 year: 2012 ident: bb1135 article-title: Microglia in Alzheimer's disease: it's all about context publication-title: Int J Alzheimers Dis – year: 2012 ident: bb1160 article-title: Dementia fact sheet [Internet] – volume: 164 start-page: 1010 year: 2004 end-page: 1014 ident: bb0335 article-title: Depression and C-reactive protein in US adults: data from the third national health and nutrition examination survey publication-title: Arch Intern Med – volume: 65 year: 2004 ident: bb0655 article-title: Are mood disorders and obesity related? A review for the mental health professional publication-title: J Clin Psychiatry – volume: 31 start-page: 9 year: 2013 end-page: 22 ident: bb0060 article-title: Depression as an evolutionary strategy for defense against infection publication-title: Brain Behav Immun – volume: 178 start-page: 112 year: 2010 end-page: 115 ident: bb0450 article-title: Effects of eicosapentaenoic acid and fluoxetine on plasma cortisol, serum interleukin-1beta and interleukin-6 concentrations in patients with major depressive disorder publication-title: Psychiatry Res – volume: 63 start-page: 1037 year: 2009 end-page: 1040 ident: bb0240 article-title: Reduced mania and depression in juvenile bipolar disorder associated with long-chain omega-3 polyunsaturated fatty acid supplementation publication-title: Eur J Clin Nutr – volume: 22 start-page: 1519 year: 2013 end-page: 1534 ident: bb1035 article-title: Omega-3 polyunsaturated fatty acids for major depressive disorder publication-title: Expert Opin Investig Drugs – volume: 2 start-page: S306 year: 2010 end-page: S312 ident: bb0225 article-title: Neural plasticity after acquired brain injury: evidence from functional neuroimaging publication-title: PM R – volume: 153 start-page: 582 year: 1996 ident: bb0555 article-title: Possible antidepressant effect of minocycline publication-title: Am J Psychiatry – volume: 1179 start-page: 86 year: 2009 end-page: 105 ident: bb0810 article-title: Cytokines and glucocorticoid receptor signaling. relevance to major depression publication-title: Ann N Y Acad Sci – volume: 163 start-page: 1561 year: 2006 end-page: 1568 ident: bb0490 article-title: Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers publication-title: Am J Psychiatry – volume: 24 start-page: 1878 year: 2012 end-page: 1890 ident: bb0825 article-title: The role of glia in late-life depression publication-title: Int Psychogeriatr – volume: 42 start-page: 2561 year: 1999 end-page: 2568 ident: bb1170 article-title: Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures publication-title: Arthritis Rheum – volume: 28 start-page: 244 year: 2003 end-page: 252 ident: bb0865 article-title: Imaging brain phospholipase A2 activation in awake rats in response to the 5-HT2A/2C agonist (+/−)2,5-dimethoxy-4-iodophenyl-2-aminopropane (DOI) publication-title: Neuropsychopharmacology – volume: 15 start-page: 1105 year: 2009 end-page: 1118 ident: bb0390 article-title: Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management publication-title: Inflamm Bowel Dis – volume: 35 start-page: 39 year: 2013 end-page: 44 ident: bb0945 article-title: Psychiatric morbidity in chronic respiratory disorders in an indian service using GMHAT/PC publication-title: Gen Hosp Psychiatry – volume: 14 start-page: 65 year: 2007 end-page: 71 ident: bb0755 article-title: Effect of the COX-2 inhibitor celecoxib on behavioural and immune changes in an olfactory bulbectomised rat model of depression publication-title: Neuroimmunomodulation – volume: 235 start-page: 302 year: 2012 end-page: 317 ident: bb0975 article-title: Novel therapeutic targets in depression: minocycline as a candidate treatment publication-title: Behav Brain Res – volume: 62 start-page: 1541 year: 2013 end-page: 1551 ident: bb0370 article-title: Monocytes in coronary artery disease and atherosclerosis: where are we now? publication-title: J Am Coll Cardiol – volume: 62 start-page: 309 year: 2007 end-page: 313 ident: bb0505 article-title: Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A publication-title: Biol Psychiatry – volume: 26 start-page: 251 year: 2012 end-page: 266 ident: bb0310 article-title: Neuroimmunological effects of physical exercise in depression publication-title: Brain Behav Immun – volume: 14 start-page: 650 year: 2012 end-page: 658 ident: bb0650 article-title: Obesity in bipolar disorder: an overview publication-title: Curr Psychiatry Rep – volume: 10 start-page: 361 year: 1983 end-page: 367 ident: bb0565 article-title: Elevated levels of prostaglandin E2 and thromboxane B2 in depression publication-title: Prostaglandins Leukot Med – volume: 79 start-page: 285 year: 2004 end-page: 289 ident: bb0215 article-title: Cerebrospinal fluid interleukin (IL)-6 in unipolar major depression publication-title: J Affect Disord – volume: 309 start-page: 2250 year: 2013 end-page: 2261 ident: bb0620 article-title: Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic review publication-title: JAMA – volume: 10 start-page: 638 year: 2009 end-page: 643 ident: bb0300 article-title: The role of IL-2 and soluble IL-2R in depression and antidepressant response publication-title: Curr Opin Investig Drugs – volume: 145 start-page: 3580 year: 2004 end-page: 3589 ident: bb0955 article-title: Characterization of an interleukin-6- and adrenocorticotropin-dependent, immune-to-adrenal pathway during viral infection publication-title: Endocrinology – volume: 146 start-page: 365 year: 1989 end-page: 368 ident: bb0780 article-title: Salivary prostaglandin concentrations: possible state indicators for major depression publication-title: Am J Psychiatry – volume: 136 start-page: 110 year: 2012 end-page: 116 ident: bb1065 article-title: Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder publication-title: J Affect Disord – volume: 103 start-page: 1007 year: 2007 end-page: 1011 ident: bb0965 article-title: Aerobic exercise attenuates inducible TNF production in humans publication-title: J Appl Physiol – volume: 13 start-page: 93 year: 2011 end-page: 116 ident: bb0970 article-title: Mood disorders and obesity: understanding inflammation as a pathophysiological nexus publication-title: Neuromolecular Med – volume: 33 start-page: 335 year: 1999 end-page: 340 ident: bb0905 article-title: Immune parameters in rapid cycling bipolar patients before and after lithium treatment publication-title: J Psychiatr Res – volume: 27 start-page: 957 year: 2012 end-page: 965 ident: bb0045 article-title: Effect of pegylated interferon-alpha-2a treatment on mental health during recent hepatitis C virus infection publication-title: J Gastroenterol Hepatol – volume: 246 start-page: 199 year: 2013 end-page: 229 ident: bb0320 article-title: Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications publication-title: Neuroscience – volume: 190 start-page: 103 year: 2007 end-page: 115 ident: bb0545 article-title: Chronic fluoxetine increases cytosolic phospholipase A(2) activity and arachidonic acid turnover in brain phospholipids of the unanesthetized rat publication-title: Psychopharmacology (Berl) – volume: 88 start-page: 31 year: 2011 end-page: 35 ident: bb1115 article-title: Psychiatric disorders in patients with immune-mediated inflammatory diseases: prevalence, association with disease activity, and overall patient well-being publication-title: J Rheumatol Suppl – volume: 64 start-page: 185 year: 2001 end-page: 193 ident: bb1060 article-title: Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania publication-title: J Affect Disord – volume: 26 start-page: 1512 year: 2012 end-page: 1524 ident: bb0595 article-title: Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects publication-title: J Psychopharmacol – volume: 259 start-page: 145 year: 1999 end-page: 148 ident: bb1030 article-title: Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinal fluid of geriatric patients with major depression: no alteration of soluble gp130 publication-title: Neurosci Lett – volume: 70 start-page: 1078 year: 2009 end-page: 1090 ident: bb0380 article-title: Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature publication-title: J Clin Psychiatry – volume: 13 start-page: 24 year: 1992 end-page: 28 ident: bb0485 article-title: Sickness behavior as a new target for drug development publication-title: Trends Pharmacol Sci – volume: 343 start-page: 1139 year: 2000 end-page: 1147 ident: bb0570 article-title: Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC study group. fragmin during instability in coronary artery disease publication-title: N Engl J Med – volume: 23 start-page: 87 year: 2008 end-page: 94 ident: bb0765 article-title: Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study publication-title: Hum Psychopharmacol – volume: 19 start-page: 421 year: 2006 end-page: 427 ident: bb0325 article-title: Mood disorders: cardiovascular and diabetes comorbidity publication-title: Curr Opin Psychiatry – volume: 26 start-page: 984 year: 2009 end-page: 992 ident: bb0375 article-title: Risk and resilience: genetic and environmental influences on development of the stress response publication-title: Depress Anxiety – volume: 104 start-page: 91 year: 2007 end-page: 95 ident: bb0500 article-title: Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder publication-title: J Affect Disord – volume: 98 start-page: 1 year: 2012 end-page: 13 ident: bb1090 article-title: Relations between asthma and psychological distress: an old idea revisited publication-title: Chem Immunol Allergy – volume: 27 start-page: 405 year: 2012 end-page: 413 ident: bb0615 article-title: Targeting cyclooxygenase-2 in depression is not a viable therapeutic approach and may even aggravate the pathophysiology underpinning depression publication-title: Metab Brain Dis – volume: 37 start-page: 106 year: 2013 end-page: 112 ident: bb0460 article-title: A systematic review of oxidative stress and safety of antioxidants in diabetes: focus on islets and their defense publication-title: Diabetes Metab J – volume: 68 start-page: 167 year: 2002 end-page: 181 ident: bb0065 article-title: Mortality of patients with mood disorders: follow-up over 34–38 publication-title: J Affect Disord – volume: 61 start-page: 556 year: 2004 end-page: 563 ident: bb0920 article-title: Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression publication-title: Arch Gen Psychiatry – volume: 6 start-page: 1 year: 2013 end-page: 9 ident: bb0845 article-title: Depression and associated factors in older adults in south africa publication-title: Glob Health Action – volume: 65 start-page: 38 year: 2008 end-page: 46 ident: bb0085 article-title: Elevated brain serotonin turnover in patients with depression: effect of genotype and therapy publication-title: Arch Gen Psychiatry – volume: 14 start-page: 248 year: 2009 end-page: 254 ident: bb1145 article-title: Asthma, allergy, mood disorders, and nutrition publication-title: Eur J Med Res – volume: 32 start-page: 647.e7 year: 2010 end-page: 647.e9 ident: bb0220 article-title: Maintenance therapy of celecoxib for major depression with mimicking neuropsychological dysfunction publication-title: Gen Hosp Psychiatry – volume: 32 start-page: 323 year: 2012 end-page: 330 ident: bb0305 article-title: Infliximab, a TNF-alpha antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level publication-title: Rheumatol Int – volume: 66 start-page: 407 year: 2009 end-page: 414 ident: bb0410 article-title: Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity publication-title: Biol Psychiatry – volume: 159 start-page: 704 year: 2008 end-page: 710 ident: bb0315 article-title: Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis publication-title: Br J Dermatol – volume: 30 start-page: 85 year: 2009 end-page: 94 ident: bb0020 article-title: Pharmacological basis for the role of curcumin in chronic diseases: An age-old spice with modern targets publication-title: Trends Pharmacol Sci – volume: 31 start-page: 1 year: 2013 end-page: 8 ident: bb0880 article-title: Malaise, melancholia and madness: the evolutionary legacy of an inflammatory bias publication-title: Brain Behav Immun – volume: 89 start-page: 419 year: 2002 end-page: 424 ident: bb0520 article-title: Inflammation and coagulation factors in persons publication-title: Am J Cardiol – volume: 28 start-page: 389 year: 2011 end-page: 400 ident: bb0025 article-title: Surgical treatment of morbid obesity among patients with bipolar disorder: A research agenda publication-title: Adv Ther – volume: 40 start-page: 171 year: 1999 end-page: 176 ident: bb0550 article-title: Cerebrospinal cytokine levels in patients with acute depression publication-title: Neuropsychobiology – volume: 353 start-page: 164 year: 1991 end-page: 167 ident: bb0855 article-title: Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism publication-title: Nature – volume: 258 start-page: 300 year: 2008 end-page: 304 ident: bb0260 article-title: Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder publication-title: Eur Arch Psychiatry Clin Neurosci – volume: 119 start-page: 364 year: 2011 end-page: 376 ident: bb0230 article-title: Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E(2) concentration in rat brain publication-title: J Neurochem – volume: 1 start-page: 41 year: 2013 end-page: 49 ident: bb0675 article-title: Role of long-chain omega-3 fatty acids in psychiatric practice publication-title: PharmaNutrition – volume: 65 start-page: 1017 year: 2008 end-page: 1032 ident: bb0470 article-title: Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder publication-title: Arch Gen Psychiatry – volume: 295 start-page: 2275 year: 2006 end-page: 2285 ident: bb0140 article-title: Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials publication-title: JAMA – volume: 33 start-page: 191 year: 2012 end-page: 206 ident: bb0415 article-title: Microglia in the developing brain: a potential target with lifetime effects publication-title: Neurotoxicology – volume: 134 start-page: 217 year: 2011 end-page: 225 ident: bb0750 article-title: Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression—no influence of celecoxib treatment publication-title: J Affect Disord – volume: 65 start-page: 395 year: 2008 end-page: 407 ident: bb0815 article-title: A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes publication-title: Arch Gen Psychiatry – volume: 58 start-page: 990 year: 2010 end-page: 992 ident: bb0050 article-title: Aspirin use, depression, and cognitive impairment in later life: the health in men study publication-title: J Am Geriatr Soc – volume: 13 start-page: 711 year: 2001 end-page: 723 ident: bb0400 article-title: Effect of repeated lipopolysaccharide administration on tissue cytokine expression and hypothalamic–pituitary–adrenal axis activity in rats publication-title: J Neuroendocrinol – volume: 39 start-page: 128 year: 2010 end-page: 138 ident: bb0245 article-title: Depressive symptom outcomes of physical activity interventions: meta-analysis findings publication-title: Ann Behav Med – volume: 25 start-page: 1063 year: 2011 end-page: 1077 ident: bb0355 article-title: Voluntary exercise protects hippocampal neurons from trimethyltin injury: possible role of interleukin-6 to modulate tumor necrosis factor receptor-mediated neurotoxicity publication-title: Brain Behav Immun – volume: 42 start-page: 458 year: 2008 end-page: 468 ident: bb0680 article-title: Omega-3 fatty acid deficiency augments amphetamine-induced behavioral sensitization in adult mice: prevention by chronic lithium treatment publication-title: J Psychiatr Res – volume: 21 start-page: 901 year: 2007 end-page: 912 ident: bb0995 article-title: The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis publication-title: Brain Behav Immun – volume: 30 start-page: 297 year: 2013 end-page: 306 ident: bb0710 article-title: Cytokine targets in the brain: impact on neurotransmitters and neurocircuits publication-title: Depress Anxiety – volume: 11 start-page: 31 year: 2010 end-page: 42 ident: bb0735 article-title: COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence publication-title: Curr Opin Investig Drugs – volume: 11 start-page: 328 year: 2009 end-page: 336 ident: bb0055 article-title: Exercise and bipolar disorder: a review of neurobiological mediators publication-title: Neuromolecular Med – volume: 22 start-page: 1216 year: 2010 end-page: 1224 ident: bb0080 article-title: Preventing late-life depression: a clinical update publication-title: Int Psychogeriatr – volume: 58 start-page: 844 year: 2001 end-page: 850 ident: bb0805 article-title: Excess mortality in bipolar and unipolar disorder in sweden publication-title: Arch Gen Psychiatry – volume: 544 start-page: 1 year: 2006 end-page: 9 ident: bb1190 article-title: Protective effects of minocycline on 3,4-methylenedioxymethamphetamine-induced neurotoxicity in serotonergic and dopaminergic neurons of mouse brain publication-title: Eur J Pharmacol – volume: 18 start-page: 205 year: 2004 end-page: 213 ident: bb0205 article-title: Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy publication-title: Brain Behav Immun – volume: 67 start-page: 446 year: 2010 end-page: 457 ident: bb0285 article-title: A meta-analysis of cytokines in major depression publication-title: Biol Psychiatry – volume: 34 start-page: 170 year: 2013 end-page: 175 ident: bb0350 article-title: A comparison of clinician-rated neuropsychological and self-rated cognitive assessments in patients with asthma and rheumatologic disorders publication-title: Allergy Asthma Proc – volume: 26 start-page: 56 year: 2013 end-page: 70 ident: bb0930 article-title: Diet and the risk of unipolar depression in adults: systematic review of cohort studies publication-title: J Hum Nutr Diet – volume: 65 start-page: 732 year: 2009 end-page: 741 ident: bb0705 article-title: Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression publication-title: Biol Psychiatry – volume: 82 start-page: 309 year: 2004 end-page: 313 ident: bb0145 article-title: Cytokine production in bipolar affective disorder patients under lithium treatment publication-title: J Affect Disord – volume: 17 start-page: 175 year: 2002 end-page: 179 ident: bb1105 article-title: Serological observations in patients suffering from acute manic episodes publication-title: Hum Psychopharmacol – volume: 15 start-page: 199 year: 2001 end-page: 226 ident: bb1195 article-title: The relationship of depression and stressors to immunological assays: a meta-analytic review publication-title: Brain Behav Immun – volume: 39 start-page: 1807 year: 2012 end-page: 1813 ident: bb0770 article-title: A multidimensional model of fatigue in patients with rheumatoid arthritis publication-title: J Rheumatol – volume: 46 start-page: 273 year: 2001 end-page: 281 ident: bb0660 article-title: Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities publication-title: Can J Psychiatry – volume: 29 start-page: 141 year: 1995 end-page: 152 ident: bb0600 article-title: Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers publication-title: J Psychiatr Res – volume: 6 start-page: e28330 year: 2011 ident: bb0395 article-title: Dose-dependent effects of endotoxin on neurobehavioral functions in humans publication-title: PLoS One – volume: 23 start-page: 237 year: 2013 end-page: 244 ident: bb0935 article-title: Major depressive disorder in patients with rheumatoid arthritis publication-title: Mod Rheumatol – volume: 116 start-page: 214 year: 2009 end-page: 217 ident: bb0155 article-title: Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder publication-title: J Affect Disord – volume: 71 start-page: 171 year: 2009 end-page: 186 ident: bb0435 article-title: Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis publication-title: Psychosom Med – volume: 64 start-page: 233 year: 2008 end-page: 252 ident: bb0950 article-title: Clinical use and pharmacological properties of selective COX-2 inhibitors publication-title: Eur J Clin Pharmacol – volume: 136 start-page: 1 year: 1974 end-page: 186 ident: bb1150 article-title: The effect of hormones and vitamin B6 on urinary excretion of metabolites of the kynurenine pathway publication-title: Scand J Clin Lab Invest Suppl – volume: 68 start-page: 1867 year: 2007 end-page: 1875 ident: bb0115 article-title: Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized, placebo-controlled trial publication-title: J Clin Psychiatry – volume: 26 start-page: 797 year: 2001 end-page: 808 ident: bb0190 article-title: Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy publication-title: Psychoneuroendocrinology – volume: 12 start-page: 28 year: 2011 end-page: 34 ident: bb0095 article-title: Translational research approach to biological and modifiable risk factors of psychosis and affective disorders publication-title: World J Biol Psychiatry – volume: 24 start-page: 91 year: 2012 end-page: 109 ident: bb0900 article-title: The canadian network for mood and anxiety treatments (CANMAT) task force recommendations for the management of patients with mood disorders and select comorbid medical conditions publication-title: Ann Clin Psychiatry – volume: 292 start-page: 1724 year: 2004 end-page: 1737 ident: bb0175 article-title: Bariatric surgery: a systematic review and meta-analysis publication-title: JAMA – volume: 177 start-page: 390 year: 2000 end-page: 395 ident: bb0685 article-title: Future therapeutic targets in mood disorders: the glucocorticoid receptor publication-title: Br J Psychiatry – volume: 79 start-page: 1 year: 1999 end-page: 71 ident: bb1070 article-title: Regulation of the hypothalamic–pituitary–adrenal axis by cytokines: actions and mechanisms of action publication-title: Physiol Rev – volume: 79 start-page: 101 year: 2008 end-page: 108 ident: bb0180 article-title: The relationship between the fatty acid composition of immune cells and their function publication-title: Prostaglandins Leukot Essent Fatty Acids – volume: 54 start-page: 906 year: 2003 end-page: 914 ident: bb0200 article-title: Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment publication-title: Biol Psychiatry – volume: 12 start-page: 6 year: 2006 end-page: 33 ident: bb0330 article-title: Interleukin-6 in acute exercise and training: what is the biological relevance? publication-title: Exerc Immunol Rev – volume: 33 start-page: 143 year: 1998 end-page: 154 ident: bb1120 article-title: Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism publication-title: Neurochem Int – volume: 11 start-page: 11 year: 2013 end-page: 74 ident: bb0120 article-title: Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness publication-title: BMC Med – volume: 22 start-page: 370 year: 2000 end-page: 379 ident: bb0535 article-title: Cytokine production and treatment response in major depressive disorder publication-title: Neuropsychopharmacology – volume: 13 year: 2013 ident: bb0870 article-title: The association between diet quality, dietary patterns and depression in adults: a systematic review publication-title: BMC Psychiatry – volume: 29 start-page: 891 year: 2005 end-page: 909 ident: bb0290 article-title: Cytokines as mediators of depression: what can we learn from animal studies? publication-title: Neurosci Biobehav Rev – volume: 45 start-page: 989 year: 1999 end-page: 994 ident: bb1055 article-title: Activation of indices of cell-mediated immunity in bipolar mania publication-title: Biol Psychiatry – volume: 352 start-page: 1714 year: 1998 ident: bb0895 article-title: The nobel chronicles. 1927: Julius Wagner-Jauregg (1857–1940) publication-title: Lancet – volume: 12 start-page: 1143 year: 2012 end-page: 1161 ident: bb0670 article-title: Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target? publication-title: Expert Rev Neurother – volume: 41 start-page: 1436 year: 2012 end-page: 1444 ident: bb0585 article-title: The association of asthma and wheezing with major depressive episodes: an analysis of 245 727 women and men from 57 countries publication-title: Int J Epidemiol – volume: 2012 start-page: 683680 year: 2012 ident: bb1050 article-title: Aspects of inflammation and oxidative stress in pediatric obesity and type 1 diabetes: an overview of ten years of studies publication-title: Exp Diabetes Res – volume: 58 start-page: 445 year: 2001 end-page: 452 ident: bb0915 article-title: Cytokine-associated emotional and cognitive disturbances in humans publication-title: Arch Gen Psychiatry – volume: 3 start-page: 41 year: 2012 ident: bb0295 article-title: Microglial activation - tuning and pruning adult neurogenesis publication-title: Front Pharmacol – volume: 40 start-page: 405 year: 1983 end-page: 406 ident: bb0575 article-title: CSF prostaglandin levels in depressed and schizophrenic patients publication-title: Arch Gen Psychiatry – volume: 36 start-page: 114 year: 2011 end-page: 118 ident: bb0980 article-title: Elevation of cerebrospinal fluid interleukin-1ss in bipolar disorder publication-title: J Psychiatry Neurosci – volume: 22 start-page: 977 year: 2010 end-page: 983 ident: bb0830 article-title: Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction publication-title: Cell Signal – volume: 41 start-page: 15 year: 2011 end-page: 28 ident: bb0210 article-title: Exercise for the treatment of depression and anxiety publication-title: Int J Psychiatry Med – volume: 17 start-page: 24 year: 2003 end-page: 38 ident: bb0635 article-title: Diabetes, oxidative stress, and antioxidants: a review publication-title: J Biochem Mol Toxicol – volume: 34 start-page: 1050 year: 2009 end-page: 1055 ident: bb0405 article-title: Leisure time physical activity, risk of depressive symptoms, and inflammatory mediators: the English longitudinal study of ageing publication-title: Psychoneuroendocrinology – volume: 26 start-page: 19 year: 2013 end-page: 26 ident: bb1000 article-title: Is bipolar disorder an inflammatory condition? The relevance of microglial activation publication-title: Curr Opin Psychiatry – volume: 78 start-page: 2081 year: 2006 end-page: 2087 ident: bb0630 article-title: Multiple biological activities of curcumin: a short review publication-title: Life Sci – volume: 9 start-page: 46 year: 2008 end-page: 56 ident: bb0270 article-title: From inflammation to sickness and depression: when the immune system subjugates the brain publication-title: Nat Rev Neurosci – volume: 12 start-page: 225 year: 2012 end-page: 229 ident: bb0075 article-title: Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry publication-title: Autoimmun Rev – volume: 21 start-page: 479 year: 2011 end-page: 484 ident: bb0385 article-title: Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders publication-title: J Child Adolesc Psychopharmacol – volume: 38 start-page: 537 year: 1991 end-page: 559 ident: bb0745 article-title: Steroids and depression publication-title: J Steroid Biochem Mol Biol – volume: 5 start-page: 401 year: 2002 end-page: 412 ident: bb0480 article-title: Effects of antidepressants on the production of cytokines publication-title: Int J Neuropsychopharmacol – volume: 41 start-page: 253 year: 2012 end-page: 259 ident: bb0720 article-title: Concurrent psychiatric disorders are associated with significantly poorer quality of life in patients with rheumatoid arthritis publication-title: Scand J Rheumatol – volume: 68 start-page: 675 year: 2011 end-page: 690 ident: bb0475 article-title: Structural neuroimaging studies in major depressive disorder. meta-analysis and comparison with bipolar disorder publication-title: Arch Gen Psychiatry – volume: 368 start-page: 1907 year: 2013 end-page: 1917 ident: bb0560 article-title: Current and future therapies for hepatitis C virus infection publication-title: N Engl J Med – volume: 70 start-page: 31 year: 2013 end-page: 41 ident: bb0890 article-title: A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers publication-title: JAMA Psychiatry – volume: 23 start-page: 326 year: 1988 end-page: 334 ident: bb0790 article-title: Increased level of salivary prostaglandins in patients with major depression publication-title: Biol Psychiatry – volume: 24 start-page: 531 year: 2001 end-page: 544 ident: bb1175 article-title: Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents publication-title: Neuropsychopharmacology – volume: 31 start-page: 370 year: 2007 end-page: 372 ident: bb0440 article-title: High-sensitivity C-reactive protein levels in patients with major depressive disorder and bipolar mania publication-title: Prog Neuropsychopharmacol Biol Psychiatry – volume: 147 start-page: 1656 year: 1990 end-page: 1661 ident: bb1110 article-title: Psychiatric illness and irritable bowel syndrome: a comparison with inflammatory bowel disease publication-title: Am J Psychiatry – volume: 2 year: 2012 ident: bb0940 article-title: Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2x2 clinical trial publication-title: BMJ Open – volume: 32 start-page: 42 year: 2008 end-page: 48 ident: bb0130 article-title: The effect of atypical antipsychotics, perospirone, ziprasidone and quetiapine on microglial activation induced by interferon-gamma publication-title: Prog Neuropsychopharmacol Biol Psychiatry – volume: 47 start-page: 1521 year: 2013 end-page: 1529 ident: bb0695 article-title: Effects of doxycycline on depressive-like behavior in mice after lipopolysaccharide (LPS) administration publication-title: J Psychiatr Res – volume: 19 start-page: 94 year: 2005 end-page: 101 ident: bb0725 article-title: Metabolism, lifestyle and bipolar affective disorder publication-title: J Psychopharmacol – volume: 24 start-page: 140 year: 2008 end-page: 147 ident: bb0740 article-title: Dietary intake of folate, other B vitamins, and omega-3 polyunsaturated fatty acids in relation to depressive symptoms in japanese adults publication-title: Nutrition – volume: 26 start-page: 607 year: 2009 end-page: 611 ident: bb0040 article-title: Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial publication-title: Depress Anxiety – volume: 69 start-page: 1 year: 2006 end-page: 20 ident: bb0430 article-title: A guide to the genetics of psychiatric disease publication-title: Psychiatry – volume: 12 start-page: 123 year: 1988 end-page: 137 ident: bb0420 article-title: Biological basis of the behavior of sick animals publication-title: Neurosci Biobehav Rev – volume: 12 year: 2012 ident: bb0255 article-title: Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the depression, anxiety and stress scale (DASS) and the hospital, anxiety and depression scale (HADS) publication-title: BMC Psychiatry – volume: 21 start-page: 227 year: 2006 end-page: 231 ident: bb0700 article-title: Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study publication-title: Int Clin Psychopharmacol – year: 2012 ident: bb0005 article-title: Cellular and molecular immunology – volume: 51 start-page: 1049 year: 2010 end-page: 1056 ident: bb0090 article-title: Lithium modifies brain arachidonic and docosahexaenoic metabolism in rat lipopolysaccharide model of neuroinflammation publication-title: J Lipid Res – volume: 82 start-page: 9 year: 2010 end-page: 14 ident: bb1010 article-title: Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder publication-title: Prostaglandins Leukot Essent Fatty Acids – volume: 136 start-page: 443 year: 2002 end-page: 453 ident: bb0070 article-title: Serotonin brain circuits involved in major depression and suicide publication-title: Prog Brain Res – volume: 27 start-page: 85 year: 2003 end-page: 102 ident: bb1100 article-title: Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review publication-title: Prog Neuropsychopharmacol Biol Psychiatry – volume: 3 start-page: CD004366 year: 2009 ident: bb0690 article-title: Exercise for depression publication-title: Cochrane Database Syst Rev – volume: 53 start-page: 157 year: 2003 end-page: 165 ident: bb0150 article-title: High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder publication-title: Biol Psychiatry – volume: 110 start-page: 255 year: 2003 end-page: 258 ident: bb1095 article-title: The mechanism of action of aspirin publication-title: Thromb Res – volume: 153 start-page: 242 year: 2001 end-page: 250 ident: bb0360 article-title: Association between physical activity and markers of inflammation in a healthy elderly population publication-title: Am J Epidemiol – volume: 35 start-page: 702 year: 2011 end-page: 721 ident: bb0610 article-title: The new ‘5-HT’ hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression publication-title: Prog Neuropsychopharmacol Biol Psychiatry – volume: 2 start-page: 525 year: 2012 end-page: 531 ident: bb0135 article-title: Gene expression profiles associated with depression in patients with chronic hepatitis C (CH-C) publication-title: Brain Behav – volume: 22 start-page: 409 year: 2013 end-page: 416 ident: bb0820 article-title: Depression and systemic lupus erythematosus: a systematic review publication-title: Lupus – volume: 9 start-page: 743 year: 2007 end-page: 753 ident: bb0510 article-title: An imbalance in the production of IL-1beta and IL-6 by monocytes of bipolar patients: restoration by lithium treatment publication-title: Bipolar Disord – volume: 15 start-page: 602 year: 2010 end-page: 614 ident: bb0540 article-title: Chronic imipramine but not bupropion increases arachidonic acid signaling in rat brain: is this related to ‘switching’ in bipolar disorder? publication-title: Mol Psychiatry – volume: 188 start-page: 48 year: 2011 end-page: 54 ident: bb0860 article-title: Rat strain differences in restraint stress-induced brain cytokines publication-title: Neuroscience – volume: 9 start-page: 3 year: 2003 end-page: 24 ident: bb0110 article-title: Endotoxin and the hypothalamo–pituitary–adrenal (HPA) axis publication-title: J Endotoxin Res – volume: 9 start-page: 596 year: 2007 end-page: 602 ident: bb0800 article-title: Immune variations in bipolar disorder: phasic differences publication-title: Bipolar Disord – volume: 285 start-page: E433 year: 2003 end-page: E437 ident: bb0990 article-title: IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans publication-title: Am J Physiol Endocrinol Metab – volume: 340 start-page: 1888 year: 1999 end-page: 1899 ident: bb1155 article-title: Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs publication-title: N Engl J Med – volume: 9 start-page: 759 year: 2007 end-page: 765 ident: bb1040 article-title: Plasma free polyunsaturated fatty acid levels are associated with symptom severity in acute mania publication-title: Bipolar Disord – volume: 80 start-page: 606 year: 2013 end-page: 612 ident: bb0165 article-title: Is there a role for curcumin in the treatment of bipolar disorder? publication-title: Med Hypotheses – volume: 15 start-page: 1563 year: 2009 end-page: 1586 ident: bb0590 article-title: Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today publication-title: Curr Pharm Des – volume: 37 start-page: 222 year: 2012 end-page: 226 ident: bb0715 article-title: Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study publication-title: Prog Neuropsychopharmacol Biol Psychiatry – volume: 24 start-page: 983 year: 2010 end-page: 996 ident: bb0665 article-title: Preventative strategies for early-onset bipolar disorder: towards a clinical staging model publication-title: CNS Drugs – volume: 18 start-page: 187 year: 2010 end-page: 199 ident: bb0795 article-title: A study on the mechanisms by which minocycline protects against MDMA (‘ecstasy’)-induced neurotoxicity of 5-HT cortical neurons publication-title: Neurotox Res – volume: 367 start-page: 29 year: 2006 end-page: 35 ident: bb1075 article-title: Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial publication-title: Lancet – volume: 90 start-page: 263 year: 2006 end-page: 267 ident: bb0785 article-title: Cytokine profiles in bipolar affective disorder: focus on acutely ill patients publication-title: J Affect Disord – volume: 160 start-page: 1554 year: 2003 end-page: 1565 ident: bb0885 article-title: When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders publication-title: Am J Psychiatry – volume: 31 start-page: 952 year: 2007 end-page: 955 ident: bb0280 article-title: Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder publication-title: Prog Neuropsychopharmacol Biol Psychiatry – volume: 54 start-page: 438 year: 1991 end-page: 463 ident: bb0960 article-title: Omega-3 fatty acids in health and disease and in growth and development publication-title: Am J Clin Nutr – volume: 105 start-page: 1785 year: 2002 end-page: 1790 ident: bb1125 article-title: Physical activity and hemostatic and inflammatory variables in elderly men publication-title: Circulation – volume: 21 start-page: 319 year: 2008 end-page: 324 ident: bb0275 article-title: Evaluation of C-reactive protein and total serum cholesterol in adult patients with bipolar disorder publication-title: Int J Immunopathol Pharmacol – volume: 22 start-page: 101 year: 2005 end-page: 110 ident: bb0850 article-title: The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab publication-title: Aliment Pharmacol Ther – volume: 116 start-page: 777 year: 2009 end-page: 784 ident: bb1025 article-title: Physical activity, exercise, depression and anxiety disorders publication-title: J Neural Transm – volume: 28 start-page: 3 year: 2007 end-page: 9 ident: bb0760 article-title: The burden of allergic rhinitis publication-title: Allergy Asthma Proc – volume: 15 start-page: 183 year: 2012 end-page: 187 ident: bb0580 article-title: The role of interleukin (IL)-17 in anxiety and depression of patients with rheumatoid arthritis publication-title: Int J Rheum Dis – volume: 141 start-page: 308 year: 2012 end-page: 314 ident: bb0010 article-title: Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study publication-title: J Affect Disord – volume: 34 start-page: 301 year: 1995 end-page: 309 ident: bb0605 article-title: Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression publication-title: J Affect Disord – volume: 73 start-page: 1128 year: 2012 end-page: 1138 ident: bb1080 article-title: Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis publication-title: J Clin Psychiatry – volume: 7 start-page: 468 year: 2002 end-page: 473 ident: bb0195 article-title: Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy publication-title: Mol Psychiatry – volume: 22 start-page: 1869 year: 2002 end-page: 1876 ident: bb0235 article-title: Associations between cardiorespiratory fitness and C-reactive protein in men publication-title: Arterioscler Thromb Vasc Biol – year: 2013 ident: bb0030 article-title: The effect of bariatric surgery on psychiatric course among patients with bipolar disorder publication-title: Bipolar Disord – volume: 157 start-page: 1275 year: 2007 end-page: 1277 ident: bb0530 article-title: Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks publication-title: Br J Dermatol – volume: 216 start-page: 753 year: 2011 end-page: 762 ident: bb0625 article-title: Macrophages in skin injury and repair publication-title: Immunobiology – volume: 13 start-page: 13 year: 2010 end-page: 25 ident: bb0910 article-title: Exercise and adolescent mental health: new evidence from longitudinal data publication-title: J Ment Health Policy Econ – volume: 23 start-page: 217 year: 2009 end-page: 224 ident: bb0170 article-title: Synergistic effects of psychological and immune stressors on inflammatory cytokine and sickness responses in humans publication-title: Brain Behav Immun – volume: 110 start-page: 161 year: 2010 end-page: 169 ident: bb0640 article-title: The effect of aerobic versus strength-based training on high-sensitivity C-reactive protein in older adults publication-title: Eur J Appl Physiol – volume: 32 start-page: 61 year: 2012 end-page: 64 ident: bb0365 article-title: Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder publication-title: J Clin Psychopharmacol – volume: 94 start-page: 1153 year: 2009 end-page: 1160 ident: bb0835 article-title: Role of exercise-induced brain-derived neurotrophic factor production in the regulation of energy homeostasis in mammals publication-title: Exp Physiol – volume: 38 start-page: 303 year: 2001 end-page: 308 ident: bb1180 article-title: Peripheral interleukin-6 administration increases extracellular concentrations of serotonin and the evoked release of serotonin in the rat striatum publication-title: Neurochem Int – volume: 87 start-page: 626 year: 2013 end-page: 633 ident: bb1130 article-title: Psoriasis publication-title: Am Fam Physician – volume: 30 start-page: 1381 year: 2006 end-page: 1393 ident: bb1185 article-title: Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine publication-title: Prog Neuropsychopharmacol Biol Psychiatry – volume: 57 start-page: 189 year: 2004 end-page: 194 ident: bb1020 article-title: Mild acute inflammatory stimulation induces transient negative mood publication-title: J Psychosom Res – volume: 52 start-page: 46 year: 2007 end-page: 54 ident: bb0125 article-title: Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods publication-title: Can J Psychiatry – volume: 18 start-page: 227 year: 2012 end-page: 237 ident: bb0345 article-title: Refractoriness in bipolar disorder: definitions and evidence-based treatment publication-title: CNS Neurosci Ther – volume: 59 start-page: 913 year: 2002 end-page: 919 ident: bb0840 article-title: A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs publication-title: Arch Gen Psychiatry – volume: 72 start-page: 895 issue: 6 year: 2013 ident: 10.1016/j.pnpbp.2014.01.013_bb1085 article-title: Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch rheumatoid arthritis monitoring (DREAM) registry publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2012-201338 – volume: 68 start-page: 1867 issue: 12 year: 2007 ident: 10.1016/j.pnpbp.2014.01.013_bb0115 article-title: Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized, placebo-controlled trial publication-title: J Clin Psychiatry doi: 10.4088/JCP.v68n1206 – volume: 9 start-page: 46 issue: 1 year: 2008 ident: 10.1016/j.pnpbp.2014.01.013_bb0270 article-title: From inflammation to sickness and depression: when the immune system subjugates the brain publication-title: Nat Rev Neurosci doi: 10.1038/nrn2297 – volume: 21 start-page: 319 issue: 2 year: 2008 ident: 10.1016/j.pnpbp.2014.01.013_bb0275 article-title: Evaluation of C-reactive protein and total serum cholesterol in adult patients with bipolar disorder publication-title: Int J Immunopathol Pharmacol doi: 10.1177/039463200802100208 – volume: 12 start-page: 28 issue: Suppl. 1 year: 2011 ident: 10.1016/j.pnpbp.2014.01.013_bb0095 article-title: Translational research approach to biological and modifiable risk factors of psychosis and affective disorders publication-title: World J Biol Psychiatry doi: 10.3109/15622975.2011.603223 – volume: 62 start-page: 207 issue: 2 year: 2007 ident: 10.1016/j.pnpbp.2014.01.013_bb1140 article-title: Interferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisol publication-title: J Psychosom Res doi: 10.1016/j.jpsychores.2006.09.007 – volume: 27 start-page: 85 issue: 1 year: 2003 ident: 10.1016/j.pnpbp.2014.01.013_bb1100 article-title: Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/S0278-5846(02)00338-X – volume: 42 start-page: 458 issue: 6 year: 2008 ident: 10.1016/j.pnpbp.2014.01.013_bb0680 article-title: Omega-3 fatty acid deficiency augments amphetamine-induced behavioral sensitization in adult mice: prevention by chronic lithium treatment publication-title: J Psychiatr Res doi: 10.1016/j.jpsychires.2007.05.009 – volume: 9 start-page: 596 issue: 6 year: 2007 ident: 10.1016/j.pnpbp.2014.01.013_bb0800 article-title: Immune variations in bipolar disorder: phasic differences publication-title: Bipolar Disord doi: 10.1111/j.1399-5618.2007.00493.x – volume: 13 start-page: 561 issue: 5 year: 2002 ident: 10.1016/j.pnpbp.2014.01.013_bb0340 article-title: Does exercise reduce inflammation? Pysical activity and C-reactive protein among U.S. adults publication-title: Epidemiology doi: 10.1097/00001648-200209000-00012 – volume: 56 start-page: 407 issue: 5 year: 1999 ident: 10.1016/j.pnpbp.2014.01.013_bb1015 article-title: Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.56.5.407 – volume: 58 start-page: 844 issue: 9 year: 2001 ident: 10.1016/j.pnpbp.2014.01.013_bb0805 article-title: Excess mortality in bipolar and unipolar disorder in sweden publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.58.9.844 – volume: 24 start-page: 1878 issue: 12 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb0825 article-title: The role of glia in late-life depression publication-title: Int Psychogeriatr doi: 10.1017/S1041610212000828 – volume: 544 start-page: 1 issue: 1–3 year: 2006 ident: 10.1016/j.pnpbp.2014.01.013_bb1190 article-title: Protective effects of minocycline on 3,4-methylenedioxymethamphetamine-induced neurotoxicity in serotonergic and dopaminergic neurons of mouse brain publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2006.05.047 – volume: 28 start-page: 389 issue: 5 year: 2011 ident: 10.1016/j.pnpbp.2014.01.013_bb0025 article-title: Surgical treatment of morbid obesity among patients with bipolar disorder: A research agenda publication-title: Adv Ther doi: 10.1007/s12325-011-0015-3 – volume: 222 start-page: 663 issue: 4 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb0495 article-title: Effects of chronic clozapine administration on markers of arachidonic acid cascade and synaptic integrity in rat brain publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-012-2671-7 – volume: 62 start-page: 309 issue: 4 year: 2007 ident: 10.1016/j.pnpbp.2014.01.013_bb0505 article-title: Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2006.09.033 – volume: 42 start-page: 2189 issue: 12 year: 2010 ident: 10.1016/j.pnpbp.2014.01.013_bb0105 article-title: Long-term physical activity and inflammatory biomarkers in older adults publication-title: Med Sci Sports Exerc doi: 10.1249/MSS.0b013e3181e3ac80 – volume: 59 start-page: 913 issue: 10 year: 2002 ident: 10.1016/j.pnpbp.2014.01.013_bb0840 article-title: A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.59.10.913 – volume: 103 start-page: 1007 issue: 3 year: 2007 ident: 10.1016/j.pnpbp.2014.01.013_bb0965 article-title: Aerobic exercise attenuates inducible TNF production in humans publication-title: J Appl Physiol doi: 10.1152/japplphysiol.00147.2007 – volume: 32 start-page: 42 issue: 1 year: 2008 ident: 10.1016/j.pnpbp.2014.01.013_bb0130 article-title: The effect of atypical antipsychotics, perospirone, ziprasidone and quetiapine on microglial activation induced by interferon-gamma publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2007.06.031 – volume: 30 start-page: 85 issue: 2 year: 2009 ident: 10.1016/j.pnpbp.2014.01.013_bb0020 article-title: Pharmacological basis for the role of curcumin in chronic diseases: An age-old spice with modern targets publication-title: Trends Pharmacol Sci doi: 10.1016/j.tips.2008.11.002 – volume: 159 start-page: 704 issue: 3 year: 2008 ident: 10.1016/j.pnpbp.2014.01.013_bb0315 article-title: Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis publication-title: Br J Dermatol doi: 10.1111/j.1365-2133.2008.08727.x – volume: 51 start-page: 1049 issue: 5 year: 2010 ident: 10.1016/j.pnpbp.2014.01.013_bb0090 article-title: Lithium modifies brain arachidonic and docosahexaenoic metabolism in rat lipopolysaccharide model of neuroinflammation publication-title: J Lipid Res doi: 10.1194/jlr.M002469 – volume: 136 start-page: 110 issue: 1–2 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb1065 article-title: Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder publication-title: J Affect Disord doi: 10.1016/j.jad.2011.08.022 – volume: 178 start-page: 112 issue: 1 year: 2010 ident: 10.1016/j.pnpbp.2014.01.013_bb0450 article-title: Effects of eicosapentaenoic acid and fluoxetine on plasma cortisol, serum interleukin-1beta and interleukin-6 concentrations in patients with major depressive disorder publication-title: Psychiatry Res doi: 10.1016/j.psychres.2009.04.013 – volume: 6 start-page: 1 year: 2013 ident: 10.1016/j.pnpbp.2014.01.013_bb0845 article-title: Depression and associated factors in older adults in south africa publication-title: Glob Health Action doi: 10.3402/gha.v6i0.18871 – volume: 22 start-page: 101 issue: 2 year: 2005 ident: 10.1016/j.pnpbp.2014.01.013_bb0850 article-title: The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab publication-title: Aliment Pharmacol Ther doi: 10.1111/j.1365-2036.2005.02535.x – volume: 64 start-page: 185 issue: 2–3 year: 2001 ident: 10.1016/j.pnpbp.2014.01.013_bb1060 article-title: Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania publication-title: J Affect Disord doi: 10.1016/S0165-0327(00)00252-4 – volume: 177 start-page: 390 year: 2000 ident: 10.1016/j.pnpbp.2014.01.013_bb0685 article-title: Future therapeutic targets in mood disorders: the glucocorticoid receptor publication-title: Br J Psychiatry doi: 10.1192/bjp.177.5.390 – volume: 259 start-page: 145 issue: 3 year: 1999 ident: 10.1016/j.pnpbp.2014.01.013_bb1030 article-title: Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinal fluid of geriatric patients with major depression: no alteration of soluble gp130 publication-title: Neurosci Lett doi: 10.1016/S0304-3940(98)00916-1 – volume: 30 start-page: 1381 issue: 8 year: 2006 ident: 10.1016/j.pnpbp.2014.01.013_bb1185 article-title: Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2006.05.015 – volume: 42 start-page: 192 issue: 3 year: 2008 ident: 10.1016/j.pnpbp.2014.01.013_bb0445 article-title: Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder publication-title: Aust N Z J Psychiatry doi: 10.1080/00048670701827275 – volume: 23 start-page: 87 issue: 2 year: 2008 ident: 10.1016/j.pnpbp.2014.01.013_bb0765 article-title: Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study publication-title: Hum Psychopharmacol doi: 10.1002/hup.912 – volume: 19 start-page: 345 issue: 4 year: 2005 ident: 10.1016/j.pnpbp.2014.01.013_bb1165 article-title: Acute inflammation and negative mood: mediation by cytokine activation publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2004.10.003 – volume: 11 start-page: 31 issue: 1 year: 2010 ident: 10.1016/j.pnpbp.2014.01.013_bb0735 article-title: COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence publication-title: Curr Opin Investig Drugs – volume: 2012 start-page: 683680 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb1050 article-title: Aspects of inflammation and oxidative stress in pediatric obesity and type 1 diabetes: an overview of ten years of studies publication-title: Exp Diabetes Res doi: 10.1155/2012/683680 – volume: 285 start-page: E433 issue: 2 year: 2003 ident: 10.1016/j.pnpbp.2014.01.013_bb0990 article-title: IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00074.2003 – volume: 98 start-page: 1 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb1090 article-title: Relations between asthma and psychological distress: an old idea revisited publication-title: Chem Immunol Allergy doi: 10.1159/000336493 – volume: 246 start-page: 199 year: 2013 ident: 10.1016/j.pnpbp.2014.01.013_bb0320 article-title: Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications publication-title: Neuroscience doi: 10.1016/j.neuroscience.2013.04.060 – volume: 110 start-page: 255 issue: 5–6 year: 2003 ident: 10.1016/j.pnpbp.2014.01.013_bb1095 article-title: The mechanism of action of aspirin publication-title: Thromb Res doi: 10.1016/S0049-3848(03)00379-7 – volume: 15 start-page: 183 issue: 2 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb0580 article-title: The role of interleukin (IL)-17 in anxiety and depression of patients with rheumatoid arthritis publication-title: Int J Rheum Dis doi: 10.1111/j.1756-185X.2011.01673.x – volume: 3 start-page: CD004366 year: 2009 ident: 10.1016/j.pnpbp.2014.01.013_bb0690 article-title: Exercise for depression publication-title: Cochrane Database Syst Rev – volume: 353 start-page: 164 issue: 6340 year: 1991 ident: 10.1016/j.pnpbp.2014.01.013_bb0855 article-title: Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism publication-title: Nature doi: 10.1038/353164a0 – volume: 73 start-page: 1128 issue: 8 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb1080 article-title: Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis publication-title: J Clin Psychiatry doi: 10.4088/JCP.12r07694 – volume: 58 start-page: 445 issue: 5 year: 2001 ident: 10.1016/j.pnpbp.2014.01.013_bb0915 article-title: Cytokine-associated emotional and cognitive disturbances in humans publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.58.5.445 – volume: 368 start-page: 1907 issue: 20 year: 2013 ident: 10.1016/j.pnpbp.2014.01.013_bb0560 article-title: Current and future therapies for hepatitis C virus infection publication-title: N Engl J Med doi: 10.1056/NEJMra1213651 – volume: 116 start-page: 777 issue: 6 year: 2009 ident: 10.1016/j.pnpbp.2014.01.013_bb1025 article-title: Physical activity, exercise, depression and anxiety disorders publication-title: J Neural Transm doi: 10.1007/s00702-008-0092-x – volume: 38 start-page: 303 issue: 4 year: 2001 ident: 10.1016/j.pnpbp.2014.01.013_bb1180 article-title: Peripheral interleukin-6 administration increases extracellular concentrations of serotonin and the evoked release of serotonin in the rat striatum publication-title: Neurochem Int doi: 10.1016/S0197-0186(00)00099-1 – volume: 68 start-page: 675 issue: 7 year: 2011 ident: 10.1016/j.pnpbp.2014.01.013_bb0475 article-title: Structural neuroimaging studies in major depressive disorder. meta-analysis and comparison with bipolar disorder publication-title: Arch Gen Psychiatry doi: 10.1001/archgenpsychiatry.2011.60 – volume: 367 start-page: 29 issue: 9504 year: 2006 ident: 10.1016/j.pnpbp.2014.01.013_bb1075 article-title: Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial publication-title: Lancet doi: 10.1016/S0140-6736(05)67763-X – volume: 140 start-page: 82 issue: 1 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb0160 article-title: Towards a multifactorial approach for prediction of bipolar disorder in at risk populations publication-title: J Affect Disord doi: 10.1016/j.jad.2012.02.016 – volume: 24 start-page: 140 issue: 2 year: 2008 ident: 10.1016/j.pnpbp.2014.01.013_bb0740 article-title: Dietary intake of folate, other B vitamins, and omega-3 polyunsaturated fatty acids in relation to depressive symptoms in japanese adults publication-title: Nutrition doi: 10.1016/j.nut.2007.10.013 – volume: 110 start-page: 161 issue: 1 year: 2010 ident: 10.1016/j.pnpbp.2014.01.013_bb0640 article-title: The effect of aerobic versus strength-based training on high-sensitivity C-reactive protein in older adults publication-title: Eur J Appl Physiol doi: 10.1007/s00421-010-1488-5 – volume: 26 start-page: 251 issue: 2 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb0310 article-title: Neuroimmunological effects of physical exercise in depression publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2011.09.015 – volume: 65 start-page: 1017 issue: 9 year: 2008 ident: 10.1016/j.pnpbp.2014.01.013_bb0470 article-title: Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.65.9.1017 – volume: 58 start-page: 990 issue: 5 year: 2010 ident: 10.1016/j.pnpbp.2014.01.013_bb0050 article-title: Aspirin use, depression, and cognitive impairment in later life: the health in men study publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.2010.02827.x – volume: 33 start-page: 143 issue: 2 year: 1998 ident: 10.1016/j.pnpbp.2014.01.013_bb1120 article-title: Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism publication-title: Neurochem Int doi: 10.1016/S0197-0186(98)00016-3 – volume: 65 start-page: 788 issue: 8 year: 2011 ident: 10.1016/j.pnpbp.2014.01.013_bb0985 article-title: Curcumin prevents haloperidol-induced development of abnormal oro-facial movements: possible implications of bcl-XL in its mechanism of action publication-title: Synapse doi: 10.1002/syn.20905 – volume: 89 start-page: 419 issue: 4 year: 2002 ident: 10.1016/j.pnpbp.2014.01.013_bb0520 article-title: Inflammation and coagulation factors in persons>65years of age with symptoms of depression but without evidence of myocardial ischemia publication-title: Am J Cardiol doi: 10.1016/S0002-9149(01)02264-0 – volume: 153 start-page: 582 issue: 4 year: 1996 ident: 10.1016/j.pnpbp.2014.01.013_bb0555 article-title: Possible antidepressant effect of minocycline publication-title: Am J Psychiatry doi: 10.1176/ajp.153.4.582b – volume: 26 start-page: 56 issue: 1 year: 2013 ident: 10.1016/j.pnpbp.2014.01.013_bb0930 article-title: Diet and the risk of unipolar depression in adults: systematic review of cohort studies publication-title: J Hum Nutr Diet doi: 10.1111/j.1365-277X.2012.01283.x – volume: 1179 start-page: 86 year: 2009 ident: 10.1016/j.pnpbp.2014.01.013_bb0810 article-title: Cytokines and glucocorticoid receptor signaling. relevance to major depression publication-title: Ann N Y Acad Sci doi: 10.1111/j.1749-6632.2009.04984.x – volume: 163 start-page: 1561 issue: 9 year: 2006 ident: 10.1016/j.pnpbp.2014.01.013_bb0490 article-title: Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers publication-title: Am J Psychiatry doi: 10.1176/ajp.2006.163.9.1561 – volume: 47 start-page: 1521 issue: 10 year: 2013 ident: 10.1016/j.pnpbp.2014.01.013_bb0695 article-title: Effects of doxycycline on depressive-like behavior in mice after lipopolysaccharide (LPS) administration publication-title: J Psychiatr Res doi: 10.1016/j.jpsychires.2013.06.008 – volume: 24 start-page: 91 issue: 1 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb0900 article-title: The canadian network for mood and anxiety treatments (CANMAT) task force recommendations for the management of patients with mood disorders and select comorbid medical conditions publication-title: Ann Clin Psychiatry – volume: 352 start-page: 1714 issue: 9141 year: 1998 ident: 10.1016/j.pnpbp.2014.01.013_bb0895 article-title: The nobel chronicles. 1927: Julius Wagner-Jauregg (1857–1940) publication-title: Lancet doi: 10.1016/S0140-6736(05)61500-0 – volume: 69 start-page: 1 issue: 1 year: 2006 ident: 10.1016/j.pnpbp.2014.01.013_bb0430 article-title: A guide to the genetics of psychiatric disease publication-title: Psychiatry doi: 10.1521/psyc.2006.69.1.1 – volume: 64 start-page: 233 issue: 3 year: 2008 ident: 10.1016/j.pnpbp.2014.01.013_bb0950 article-title: Clinical use and pharmacological properties of selective COX-2 inhibitors publication-title: Eur J Clin Pharmacol doi: 10.1007/s00228-007-0400-7 – volume: 343 start-page: 1139 issue: 16 year: 2000 ident: 10.1016/j.pnpbp.2014.01.013_bb0570 article-title: Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC study group. fragmin during instability in coronary artery disease publication-title: N Engl J Med doi: 10.1056/NEJM200010193431602 – volume: 12 start-page: 1143 issue: 9 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb0670 article-title: Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target? publication-title: Expert Rev Neurother doi: 10.1586/ern.12.98 – volume: 34 start-page: 170 issue: 2 year: 2013 ident: 10.1016/j.pnpbp.2014.01.013_bb0350 article-title: A comparison of clinician-rated neuropsychological and self-rated cognitive assessments in patients with asthma and rheumatologic disorders publication-title: Allergy Asthma Proc doi: 10.2500/aap.2013.34.3642 – volume: 15 start-page: 199 issue: 3 year: 2001 ident: 10.1016/j.pnpbp.2014.01.013_bb1195 article-title: The relationship of depression and stressors to immunological assays: a meta-analytic review publication-title: Brain Behav Immun doi: 10.1006/brbi.2000.0597 – volume: 63 start-page: 1037 issue: 8 year: 2009 ident: 10.1016/j.pnpbp.2014.01.013_bb0240 article-title: Reduced mania and depression in juvenile bipolar disorder associated with long-chain omega-3 polyunsaturated fatty acid supplementation publication-title: Eur J Clin Nutr doi: 10.1038/ejcn.2008.81 – volume: 53 start-page: 157 issue: 2 year: 2003 ident: 10.1016/j.pnpbp.2014.01.013_bb0150 article-title: High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder publication-title: Biol Psychiatry doi: 10.1016/S0006-3223(02)01452-X – volume: 94 start-page: 1153 issue: 12 year: 2009 ident: 10.1016/j.pnpbp.2014.01.013_bb0835 article-title: Role of exercise-induced brain-derived neurotrophic factor production in the regulation of energy homeostasis in mammals publication-title: Exp Physiol doi: 10.1113/expphysiol.2009.048561 – volume: 41 start-page: 15 issue: 1 year: 2011 ident: 10.1016/j.pnpbp.2014.01.013_bb0210 article-title: Exercise for the treatment of depression and anxiety publication-title: Int J Psychiatry Med doi: 10.2190/PM.41.1.c – volume: 104 start-page: 91 issue: 1–3 year: 2007 ident: 10.1016/j.pnpbp.2014.01.013_bb0500 article-title: Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder publication-title: J Affect Disord doi: 10.1016/j.jad.2007.02.018 – volume: 10 start-page: 638 issue: 7 year: 2009 ident: 10.1016/j.pnpbp.2014.01.013_bb0300 article-title: The role of IL-2 and soluble IL-2R in depression and antidepressant response publication-title: Curr Opin Investig Drugs – volume: 37 start-page: 106 issue: 2 year: 2013 ident: 10.1016/j.pnpbp.2014.01.013_bb0460 article-title: A systematic review of oxidative stress and safety of antioxidants in diabetes: focus on islets and their defense publication-title: Diabetes Metab J doi: 10.4093/dmj.2013.37.2.106 – volume: 8 issue: 32 year: 2010 ident: 10.1016/j.pnpbp.2014.01.013_bb0925 article-title: Physical activity and depressive symptoms in adolescents: a prospective study publication-title: BMC Med – volume: 24 start-page: 531 issue: 5 year: 2001 ident: 10.1016/j.pnpbp.2014.01.013_bb1175 article-title: Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(00)00226-8 – volume: 146 start-page: 365 issue: 3 year: 1989 ident: 10.1016/j.pnpbp.2014.01.013_bb0780 article-title: Salivary prostaglandin concentrations: possible state indicators for major depression publication-title: Am J Psychiatry doi: 10.1176/ajp.146.3.365 – volume: 90 start-page: 263 issue: 2–3 year: 2006 ident: 10.1016/j.pnpbp.2014.01.013_bb0785 article-title: Cytokine profiles in bipolar affective disorder: focus on acutely ill patients publication-title: J Affect Disord doi: 10.1016/j.jad.2005.11.015 – volume: 21 start-page: 227 issue: 4 year: 2006 ident: 10.1016/j.pnpbp.2014.01.013_bb0700 article-title: Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study publication-title: Int Clin Psychopharmacol doi: 10.1097/00004850-200607000-00005 – volume: 26 start-page: 1512 issue: 12 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb0595 article-title: Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects publication-title: J Psychopharmacol doi: 10.1177/0269881112458732 – volume: 34 start-page: 1050 issue: 7 year: 2009 ident: 10.1016/j.pnpbp.2014.01.013_bb0405 article-title: Leisure time physical activity, risk of depressive symptoms, and inflammatory mediators: the English longitudinal study of ageing publication-title: Psychoneuroendocrinology doi: 10.1016/j.psyneuen.2009.02.004 – volume: 15 start-page: 1563 issue: 14 year: 2009 ident: 10.1016/j.pnpbp.2014.01.013_bb0590 article-title: Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today publication-title: Curr Pharm Des doi: 10.2174/138161209788168001 – volume: 14 start-page: 837 issue: 6 year: 2007 ident: 10.1016/j.pnpbp.2014.01.013_bb0455 article-title: The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus publication-title: Eur J Cardiovasc Prev Rehabil doi: 10.1097/HJR.0b013e3282efaf50 – volume: 88 start-page: 31 year: 2011 ident: 10.1016/j.pnpbp.2014.01.013_bb1115 article-title: Psychiatric disorders in patients with immune-mediated inflammatory diseases: prevalence, association with disease activity, and overall patient well-being publication-title: J Rheumatol Suppl doi: 10.3899/jrheum.110900 – volume: 82 start-page: 9 issue: 1 year: 2010 ident: 10.1016/j.pnpbp.2014.01.013_bb1010 article-title: Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder publication-title: Prostaglandins Leukot Essent Fatty Acids doi: 10.1016/j.plefa.2009.10.007 – volume: 26 start-page: 797 issue: 8 year: 2001 ident: 10.1016/j.pnpbp.2014.01.013_bb0190 article-title: Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy publication-title: Psychoneuroendocrinology doi: 10.1016/S0306-4530(01)00030-0 – volume: 18 start-page: 205 issue: 3 year: 2004 ident: 10.1016/j.pnpbp.2014.01.013_bb0205 article-title: Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2003.11.004 – volume: 190 start-page: 103 issue: 1 year: 2007 ident: 10.1016/j.pnpbp.2014.01.013_bb0545 article-title: Chronic fluoxetine increases cytosolic phospholipase A(2) activity and arachidonic acid turnover in brain phospholipids of the unanesthetized rat publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-006-0582-1 – volume: 12 start-page: 123 issue: 2 year: 1988 ident: 10.1016/j.pnpbp.2014.01.013_bb0420 article-title: Biological basis of the behavior of sick animals publication-title: Neurosci Biobehav Rev doi: 10.1016/S0149-7634(88)80004-6 – volume: 105 start-page: 1785 issue: 15 year: 2002 ident: 10.1016/j.pnpbp.2014.01.013_bb1125 article-title: Physical activity and hemostatic and inflammatory variables in elderly men publication-title: Circulation doi: 10.1161/hc1502.107117 – volume: 5 start-page: 401 issue: 4 year: 2002 ident: 10.1016/j.pnpbp.2014.01.013_bb0480 article-title: Effects of antidepressants on the production of cytokines publication-title: Int J Neuropsychopharmacol doi: 10.1017/S1461145702003164 – volume: 295 start-page: 2275 issue: 19 year: 2006 ident: 10.1016/j.pnpbp.2014.01.013_bb0140 article-title: Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials publication-title: JAMA doi: 10.1001/jama.295.19.2275 – volume: 78 start-page: 2081 issue: 18 year: 2006 ident: 10.1016/j.pnpbp.2014.01.013_bb0630 article-title: Multiple biological activities of curcumin: a short review publication-title: Life Sci doi: 10.1016/j.lfs.2005.12.007 – volume: 12 start-page: 6 year: 2006 ident: 10.1016/j.pnpbp.2014.01.013_bb0330 article-title: Interleukin-6 in acute exercise and training: what is the biological relevance? publication-title: Exerc Immunol Rev – volume: 164 start-page: 1010 issue: 9 year: 2004 ident: 10.1016/j.pnpbp.2014.01.013_bb0335 article-title: Depression and C-reactive protein in US adults: data from the third national health and nutrition examination survey publication-title: Arch Intern Med doi: 10.1001/archinte.164.9.1010 – volume: 54 start-page: 438 issue: 3 year: 1991 ident: 10.1016/j.pnpbp.2014.01.013_bb0960 article-title: Omega-3 fatty acids in health and disease and in growth and development publication-title: Am J Clin Nutr doi: 10.1093/ajcn/54.3.438 – volume: 26 start-page: 984 issue: 11 year: 2009 ident: 10.1016/j.pnpbp.2014.01.013_bb0375 article-title: Risk and resilience: genetic and environmental influences on development of the stress response publication-title: Depress Anxiety doi: 10.1002/da.20605 – volume: 62 start-page: 1541 issue: 17 year: 2013 ident: 10.1016/j.pnpbp.2014.01.013_bb0370 article-title: Monocytes in coronary artery disease and atherosclerosis: where are we now? publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2013.07.043 – volume: 31 start-page: 1 year: 2013 ident: 10.1016/j.pnpbp.2014.01.013_bb0880 article-title: Malaise, melancholia and madness: the evolutionary legacy of an inflammatory bias publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2013.04.009 – volume: 57 start-page: 189 issue: 2 year: 2004 ident: 10.1016/j.pnpbp.2014.01.013_bb1020 article-title: Mild acute inflammatory stimulation induces transient negative mood publication-title: J Psychosom Res doi: 10.1016/S0022-3999(03)00569-5 – volume: 19 start-page: 389 issue: 5 year: 2005 ident: 10.1016/j.pnpbp.2014.01.013_bb1005 article-title: Influence of exercise training and age on CD14+ cell-surface expression of toll-like receptor 2 and 4 publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2005.04.003 – volume: 27 start-page: 957 issue: 5 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb0045 article-title: Effect of pegylated interferon-alpha-2a treatment on mental health during recent hepatitis C virus infection publication-title: J Gastroenterol Hepatol doi: 10.1111/j.1440-1746.2011.07035.x – volume: 28 start-page: 3 issue: 1 year: 2007 ident: 10.1016/j.pnpbp.2014.01.013_bb0760 article-title: The burden of allergic rhinitis publication-title: Allergy Asthma Proc doi: 10.2500/aap.2007.28.2934 – volume: 31 start-page: 9 year: 2013 ident: 10.1016/j.pnpbp.2014.01.013_bb0060 article-title: Depression as an evolutionary strategy for defense against infection publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2012.12.002 – volume: 33 start-page: 191 issue: 2 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb0415 article-title: Microglia in the developing brain: a potential target with lifetime effects publication-title: Neurotoxicology doi: 10.1016/j.neuro.2012.01.012 – volume: 9 start-page: 743 issue: 7 year: 2007 ident: 10.1016/j.pnpbp.2014.01.013_bb0510 article-title: An imbalance in the production of IL-1beta and IL-6 by monocytes of bipolar patients: restoration by lithium treatment publication-title: Bipolar Disord doi: 10.1111/j.1399-5618.2007.00444.x – volume: 136 start-page: 1 year: 1974 ident: 10.1016/j.pnpbp.2014.01.013_bb1150 article-title: The effect of hormones and vitamin B6 on urinary excretion of metabolites of the kynurenine pathway publication-title: Scand J Clin Lab Invest Suppl – volume: 40 start-page: 405 issue: 4 year: 1983 ident: 10.1016/j.pnpbp.2014.01.013_bb0575 article-title: CSF prostaglandin levels in depressed and schizophrenic patients publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.1983.01790040059008 – volume: 18 start-page: 187 issue: 2 year: 2010 ident: 10.1016/j.pnpbp.2014.01.013_bb0795 article-title: A study on the mechanisms by which minocycline protects against MDMA (‘ecstasy’)-induced neurotoxicity of 5-HT cortical neurons publication-title: Neurotox Res doi: 10.1007/s12640-009-9120-3 – volume: 258 start-page: 300 issue: 5 year: 2008 ident: 10.1016/j.pnpbp.2014.01.013_bb0260 article-title: Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder publication-title: Eur Arch Psychiatry Clin Neurosci doi: 10.1007/s00406-007-0797-0 – volume: 7 start-page: 468 issue: 5 year: 2002 ident: 10.1016/j.pnpbp.2014.01.013_bb0195 article-title: Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4000995 – volume: 11 start-page: 680 issue: 7 year: 2006 ident: 10.1016/j.pnpbp.2014.01.013_bb0730 article-title: The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4001805 – volume: 92 start-page: 108 issue: 1–3 year: 2007 ident: 10.1016/j.pnpbp.2014.01.013_bb0465 article-title: Risperidone significantly inhibits interferon-gamma-induced microglial activation in vitro publication-title: Schizophr Res doi: 10.1016/j.schres.2007.01.019 – ident: 10.1016/j.pnpbp.2014.01.013_bb1160 – volume: 65 start-page: 38 issue: 1 year: 2008 ident: 10.1016/j.pnpbp.2014.01.013_bb0085 article-title: Elevated brain serotonin turnover in patients with depression: effect of genotype and therapy publication-title: Arch Gen Psychiatry doi: 10.1001/archgenpsychiatry.2007.11 – volume: 54 start-page: 906 issue: 9 year: 2003 ident: 10.1016/j.pnpbp.2014.01.013_bb0200 article-title: Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment publication-title: Biol Psychiatry doi: 10.1016/S0006-3223(03)00173-2 – volume: 65 start-page: 347 issue: 3 year: 2003 ident: 10.1016/j.pnpbp.2014.01.013_bb0265 article-title: Association between depression and elevated C-reactive protein publication-title: Psychosom Med doi: 10.1097/01.PSY.0000041542.29808.01 – volume: 6 start-page: e28330 issue: 12 year: 2011 ident: 10.1016/j.pnpbp.2014.01.013_bb0395 article-title: Dose-dependent effects of endotoxin on neurobehavioral functions in humans publication-title: PLoS One doi: 10.1371/journal.pone.0028330 – volume: 65 start-page: 395 issue: 4 year: 2008 ident: 10.1016/j.pnpbp.2014.01.013_bb0815 article-title: A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.65.4.395 – volume: 15 start-page: 602 issue: 6 year: 2010 ident: 10.1016/j.pnpbp.2014.01.013_bb0540 article-title: Chronic imipramine but not bupropion increases arachidonic acid signaling in rat brain: is this related to ‘switching’ in bipolar disorder? publication-title: Mol Psychiatry doi: 10.1038/mp.2008.117 – volume: 19 start-page: 94 issue: 6 Suppl. year: 2005 ident: 10.1016/j.pnpbp.2014.01.013_bb0725 article-title: Metabolism, lifestyle and bipolar affective disorder publication-title: J Psychopharmacol doi: 10.1177/0269881105058678 – volume: 145 start-page: 3580 issue: 8 year: 2004 ident: 10.1016/j.pnpbp.2014.01.013_bb0955 article-title: Characterization of an interleukin-6- and adrenocorticotropin-dependent, immune-to-adrenal pathway during viral infection publication-title: Endocrinology doi: 10.1210/en.2003-1421 – volume: 26 start-page: 19 issue: 1 year: 2013 ident: 10.1016/j.pnpbp.2014.01.013_bb1000 article-title: Is bipolar disorder an inflammatory condition? The relevance of microglial activation publication-title: Curr Opin Psychiatry doi: 10.1097/YCO.0b013e32835aa4b4 – volume: 2012 start-page: 314185 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb1135 article-title: Microglia in Alzheimer's disease: it's all about context publication-title: Int J Alzheimers Dis – volume: 14 start-page: 344 issue: 5 year: 1997 ident: 10.1016/j.pnpbp.2014.01.013_bb1045 article-title: Exercise training for intermittent claudication: does it adversely affect biochemical markers of the exercise-induced inflammatory response? publication-title: Eur J Vasc Endovasc Surg doi: 10.1016/S1078-5884(97)80283-3 – volume: 22 start-page: 1519 issue: 12 year: 2013 ident: 10.1016/j.pnpbp.2014.01.013_bb1035 article-title: Omega-3 polyunsaturated fatty acids for major depressive disorder publication-title: Expert Opin Investig Drugs doi: 10.1517/13543784.2013.836487 – volume: 340 start-page: 1888 issue: 24 year: 1999 ident: 10.1016/j.pnpbp.2014.01.013_bb1155 article-title: Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs publication-title: N Engl J Med doi: 10.1056/NEJM199906173402407 – volume: 18 start-page: 2143 issue: 10 year: 2000 ident: 10.1016/j.pnpbp.2014.01.013_bb0185 article-title: Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy publication-title: J Clin Oncol doi: 10.1200/JCO.2000.18.10.2143 – volume: 32 start-page: 323 issue: 2 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb0305 article-title: Infliximab, a TNF-alpha antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level publication-title: Rheumatol Int doi: 10.1007/s00296-010-1616-x – volume: 31 start-page: 952 issue: 4 year: 2007 ident: 10.1016/j.pnpbp.2014.01.013_bb0280 article-title: Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2007.02.018 – volume: 22 start-page: 1869 issue: 11 year: 2002 ident: 10.1016/j.pnpbp.2014.01.013_bb0235 article-title: Associations between cardiorespiratory fitness and C-reactive protein in men publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.0000036611.77940.F8 – volume: 32 start-page: 61 issue: 1 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb0365 article-title: Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder publication-title: J Clin Psychopharmacol doi: 10.1097/JCP.0b013e31823f3b5f – volume: 116 start-page: 214 issue: 3 year: 2009 ident: 10.1016/j.pnpbp.2014.01.013_bb0155 article-title: Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder publication-title: J Affect Disord doi: 10.1016/j.jad.2008.12.001 – volume: 188 start-page: 48 year: 2011 ident: 10.1016/j.pnpbp.2014.01.013_bb0860 article-title: Rat strain differences in restraint stress-induced brain cytokines publication-title: Neuroscience doi: 10.1016/j.neuroscience.2011.05.023 – volume: 13 start-page: 24 issue: 1 year: 1992 ident: 10.1016/j.pnpbp.2014.01.013_bb0485 article-title: Sickness behavior as a new target for drug development publication-title: Trends Pharmacol Sci doi: 10.1016/0165-6147(92)90012-U – volume: 22 start-page: 370 issue: 4 year: 2000 ident: 10.1016/j.pnpbp.2014.01.013_bb0535 article-title: Cytokine production and treatment response in major depressive disorder publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(99)00134-7 – volume: 42 start-page: 2561 issue: 12 year: 1999 ident: 10.1016/j.pnpbp.2014.01.013_bb1170 article-title: Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures publication-title: Arthritis Rheum doi: 10.1002/1529-0131(199912)42:12<2561::AID-ANR8>3.0.CO;2-U – volume: 22 start-page: 977 issue: 7 year: 2010 ident: 10.1016/j.pnpbp.2014.01.013_bb0830 article-title: Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction publication-title: Cell Signal doi: 10.1016/j.cellsig.2010.01.010 – volume: 2 start-page: S306 issue: 12 Suppl. 2 year: 2010 ident: 10.1016/j.pnpbp.2014.01.013_bb0225 article-title: Neural plasticity after acquired brain injury: evidence from functional neuroimaging publication-title: PM R doi: 10.1016/j.pmrj.2010.10.006 – volume: 65 issue: 5 year: 2004 ident: 10.1016/j.pnpbp.2014.01.013_bb0655 article-title: Are mood disorders and obesity related? A review for the mental health professional publication-title: J Clin Psychiatry doi: 10.4088/JCP.v65n0507 – volume: 124 start-page: 1651 issue: 8 year: 1998 ident: 10.1016/j.pnpbp.2014.01.013_bb0775 article-title: Direct dopamine D2-receptor-mediated modulation of arachidonic acid release in transfected CHO cells without the concomitant administration of a Ca2+-mobilizing agent publication-title: Br J Pharmacol doi: 10.1038/sj.bjp.0702025 – volume: 32 start-page: 647.e7 issue: 6 year: 2010 ident: 10.1016/j.pnpbp.2014.01.013_bb0220 article-title: Maintenance therapy of celecoxib for major depression with mimicking neuropsychological dysfunction publication-title: Gen Hosp Psychiatry doi: 10.1016/j.genhosppsych.2010.07.001 – volume: 75 start-page: 346 issue: 4 year: 1981 ident: 10.1016/j.pnpbp.2014.01.013_bb0425 article-title: The clinical significance of disordered renal excretion of xanthurenic acid in depressive patients publication-title: Psychopharmacology (Berl) doi: 10.1007/BF00435850 – volume: 35 start-page: 39 issue: 1 year: 2013 ident: 10.1016/j.pnpbp.2014.01.013_bb0945 article-title: Psychiatric morbidity in chronic respiratory disorders in an indian service using GMHAT/PC publication-title: Gen Hosp Psychiatry doi: 10.1016/j.genhosppsych.2012.09.009 – volume: 29 start-page: 891 issue: 4–5 year: 2005 ident: 10.1016/j.pnpbp.2014.01.013_bb0290 article-title: Cytokines as mediators of depression: what can we learn from animal studies? publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2005.03.023 – volume: 22 start-page: 409 issue: 5 year: 2013 ident: 10.1016/j.pnpbp.2014.01.013_bb0820 article-title: Depression and systemic lupus erythematosus: a systematic review publication-title: Lupus doi: 10.1177/0961203313477227 – volume: 79 start-page: 1 issue: 1 year: 1999 ident: 10.1016/j.pnpbp.2014.01.013_bb1070 article-title: Regulation of the hypothalamic–pituitary–adrenal axis by cytokines: actions and mechanisms of action publication-title: Physiol Rev doi: 10.1152/physrev.1999.79.1.1 – volume: 31 start-page: 370 issue: 2 year: 2007 ident: 10.1016/j.pnpbp.2014.01.013_bb0440 article-title: High-sensitivity C-reactive protein levels in patients with major depressive disorder and bipolar mania publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2006.09.010 – volume: 41 start-page: 40 issue: 1 year: 2009 ident: 10.1016/j.pnpbp.2014.01.013_bb0015 article-title: Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases publication-title: Int J Biochem Cell Biol doi: 10.1016/j.biocel.2008.06.010 – volume: 15 start-page: 1105 issue: 7 year: 2009 ident: 10.1016/j.pnpbp.2014.01.013_bb0390 article-title: Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management publication-title: Inflamm Bowel Dis doi: 10.1002/ibd.20873 – volume: 411 start-page: 785 issue: 11–12 year: 2010 ident: 10.1016/j.pnpbp.2014.01.013_bb0100 article-title: Effect of exercise training on chronic inflammation publication-title: Clin Chim Acta doi: 10.1016/j.cca.2010.02.069 – volume: 17 start-page: 24 issue: 1 year: 2003 ident: 10.1016/j.pnpbp.2014.01.013_bb0635 article-title: Diabetes, oxidative stress, and antioxidants: a review publication-title: J Biochem Mol Toxicol doi: 10.1002/jbt.10058 – volume: 12 start-page: 225 issue: 2 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb0075 article-title: Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2012.06.008 – volume: 30 start-page: 297 issue: 4 year: 2013 ident: 10.1016/j.pnpbp.2014.01.013_bb0710 article-title: Cytokine targets in the brain: impact on neurotransmitters and neurocircuits publication-title: Depress Anxiety doi: 10.1002/da.22084 – volume: 80 start-page: 606 issue: 5 year: 2013 ident: 10.1016/j.pnpbp.2014.01.013_bb0165 article-title: Is there a role for curcumin in the treatment of bipolar disorder? publication-title: Med Hypotheses doi: 10.1016/j.mehy.2013.02.001 – volume: 21 start-page: 901 issue: 7 year: 2007 ident: 10.1016/j.pnpbp.2014.01.013_bb0995 article-title: The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2007.03.011 – volume: 26 start-page: 607 issue: 7 year: 2009 ident: 10.1016/j.pnpbp.2014.01.013_bb0040 article-title: Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial publication-title: Depress Anxiety doi: 10.1002/da.20589 – volume: 79 start-page: 101 issue: 3–5 year: 2008 ident: 10.1016/j.pnpbp.2014.01.013_bb0180 article-title: The relationship between the fatty acid composition of immune cells and their function publication-title: Prostaglandins Leukot Essent Fatty Acids doi: 10.1016/j.plefa.2008.09.016 – volume: 71 start-page: 171 issue: 2 year: 2009 ident: 10.1016/j.pnpbp.2014.01.013_bb0435 article-title: Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis publication-title: Psychosom Med doi: 10.1097/PSY.0b013e3181907c1b – volume: 67 start-page: 446 issue: 5 year: 2010 ident: 10.1016/j.pnpbp.2014.01.013_bb0285 article-title: A meta-analysis of cytokines in major depression publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2009.09.033 – volume: 153 start-page: 242 issue: 3 year: 2001 ident: 10.1016/j.pnpbp.2014.01.013_bb0360 article-title: Association between physical activity and markers of inflammation in a healthy elderly population publication-title: Am J Epidemiol doi: 10.1093/aje/153.3.242 – volume: 157 start-page: 1275 issue: 6 year: 2007 ident: 10.1016/j.pnpbp.2014.01.013_bb0530 article-title: Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks publication-title: Br J Dermatol doi: 10.1111/j.1365-2133.2007.08205.x – volume: 46 start-page: 273 issue: 3 year: 2001 ident: 10.1016/j.pnpbp.2014.01.013_bb0660 article-title: Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities publication-title: Can J Psychiatry doi: 10.1177/070674370104600308 – volume: 41 start-page: 253 issue: 4 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb0720 article-title: Concurrent psychiatric disorders are associated with significantly poorer quality of life in patients with rheumatoid arthritis publication-title: Scand J Rheumatol doi: 10.3109/03009742.2012.664648 – volume: 17 start-page: 175 issue: 4 year: 2002 ident: 10.1016/j.pnpbp.2014.01.013_bb1105 article-title: Serological observations in patients suffering from acute manic episodes publication-title: Hum Psychopharmacol doi: 10.1002/hup.390 – volume: 38 start-page: 537 issue: 5 year: 1991 ident: 10.1016/j.pnpbp.2014.01.013_bb0745 article-title: Steroids and depression publication-title: J Steroid Biochem Mol Biol doi: 10.1016/0960-0760(91)90312-S – volume: 1 start-page: 41 issue: 2 year: 2013 ident: 10.1016/j.pnpbp.2014.01.013_bb0675 article-title: Role of long-chain omega-3 fatty acids in psychiatric practice publication-title: PharmaNutrition doi: 10.1016/j.phanu.2012.10.004 – volume: 23 start-page: 326 issue: 4 year: 1988 ident: 10.1016/j.pnpbp.2014.01.013_bb0790 article-title: Increased level of salivary prostaglandins in patients with major depression publication-title: Biol Psychiatry doi: 10.1016/0006-3223(88)90283-1 – volume: 75 start-page: 305 issue: 3 year: 2013 ident: 10.1016/j.pnpbp.2014.01.013_bb0035 article-title: Examining the relationship between depression and asthma exacerbations in a prospective follow-up study publication-title: Psychosom Med doi: 10.1097/PSY.0b013e3182864ee3 – volume: 27 start-page: 405 issue: 4 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb0615 article-title: Targeting cyclooxygenase-2 in depression is not a viable therapeutic approach and may even aggravate the pathophysiology underpinning depression publication-title: Metab Brain Dis doi: 10.1007/s11011-012-9326-6 – volume: 235 start-page: 302 issue: 2 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb0975 article-title: Novel therapeutic targets in depression: minocycline as a candidate treatment publication-title: Behav Brain Res doi: 10.1016/j.bbr.2012.07.026 – volume: 292 start-page: 1724 issue: 14 year: 2004 ident: 10.1016/j.pnpbp.2014.01.013_bb0175 article-title: Bariatric surgery: a systematic review and meta-analysis publication-title: JAMA doi: 10.1001/jama.292.14.1724 – volume: 20 start-page: 201 issue: 3 year: 2006 ident: 10.1016/j.pnpbp.2014.01.013_bb0515 article-title: Aerobic exercise, but not flexibility/resistance exercise, reduces serum IL-18, CRP, and IL-6 independent of beta-blockers, BMI, and psychosocial factors in older adults publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2005.12.002 – volume: 309 start-page: 2250 issue: 21 year: 2013 ident: 10.1016/j.pnpbp.2014.01.013_bb0620 article-title: Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic review publication-title: JAMA doi: 10.1001/jama.2013.4851 – volume: 39 start-page: 1807 issue: 9 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb0770 article-title: A multidimensional model of fatigue in patients with rheumatoid arthritis publication-title: J Rheumatol doi: 10.3899/jrheum.111068 – volume: 119 start-page: 364 issue: 2 year: 2011 ident: 10.1016/j.pnpbp.2014.01.013_bb0230 article-title: Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E(2) concentration in rat brain publication-title: J Neurochem doi: 10.1111/j.1471-4159.2011.07410.x – volume: 28 start-page: 244 issue: 2 year: 2003 ident: 10.1016/j.pnpbp.2014.01.013_bb0865 article-title: Imaging brain phospholipase A2 activation in awake rats in response to the 5-HT2A/2C agonist (+/−)2,5-dimethoxy-4-iodophenyl-2-aminopropane (DOI) publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300022 – volume: 23 start-page: 217 issue: 2 year: 2009 ident: 10.1016/j.pnpbp.2014.01.013_bb0170 article-title: Synergistic effects of psychological and immune stressors on inflammatory cytokine and sickness responses in humans publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2008.09.007 – volume: 39 start-page: 128 issue: 2 year: 2010 ident: 10.1016/j.pnpbp.2014.01.013_bb0245 article-title: Depressive symptom outcomes of physical activity interventions: meta-analysis findings publication-title: Ann Behav Med doi: 10.1007/s12160-010-9172-x – volume: 12 start-page: CD004366 issue: 9 year: 2013 ident: 10.1016/j.pnpbp.2014.01.013_bb0250 article-title: Exercise for depression publication-title: Cochrane Database Syst Rev – volume: 23 start-page: 237 issue: 2 year: 2013 ident: 10.1016/j.pnpbp.2014.01.013_bb0935 article-title: Major depressive disorder in patients with rheumatoid arthritis publication-title: Mod Rheumatol doi: 10.3109/s10165-012-0643-8 – volume: 9 start-page: 3 issue: 1 year: 2003 ident: 10.1016/j.pnpbp.2014.01.013_bb0110 article-title: Endotoxin and the hypothalamo–pituitary–adrenal (HPA) axis publication-title: J Endotoxin Res – volume: 52 start-page: 46 issue: 1 year: 2007 ident: 10.1016/j.pnpbp.2014.01.013_bb0125 article-title: Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods publication-title: Can J Psychiatry doi: 10.1177/070674370705200108 – volume: 34 start-page: 301 issue: 4 year: 1995 ident: 10.1016/j.pnpbp.2014.01.013_bb0605 article-title: Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression publication-title: J Affect Disord doi: 10.1016/0165-0327(95)00028-L – volume: 216 start-page: 753 issue: 7 year: 2011 ident: 10.1016/j.pnpbp.2014.01.013_bb0625 article-title: Macrophages in skin injury and repair publication-title: Immunobiology doi: 10.1016/j.imbio.2011.01.001 – volume: 11 start-page: 11 year: 2013 ident: 10.1016/j.pnpbp.2014.01.013_bb0120 article-title: Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness publication-title: BMC Med doi: 10.1186/1741-7015-11-74 – volume: 33 start-page: 335 issue: 4 year: 1999 ident: 10.1016/j.pnpbp.2014.01.013_bb0905 article-title: Immune parameters in rapid cycling bipolar patients before and after lithium treatment publication-title: J Psychiatr Res doi: 10.1016/S0022-3956(99)00007-2 – volume: 45 start-page: 989 issue: 8 year: 1999 ident: 10.1016/j.pnpbp.2014.01.013_bb1055 article-title: Activation of indices of cell-mediated immunity in bipolar mania publication-title: Biol Psychiatry doi: 10.1016/S0006-3223(98)00159-0 – volume: 160 start-page: 1554 issue: 9 year: 2003 ident: 10.1016/j.pnpbp.2014.01.013_bb0885 article-title: When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.160.9.1554 – volume: 66 start-page: 407 issue: 5 year: 2009 ident: 10.1016/j.pnpbp.2014.01.013_bb0410 article-title: Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2009.03.015 – volume: 79 start-page: 285 issue: 1–3 year: 2004 ident: 10.1016/j.pnpbp.2014.01.013_bb0215 article-title: Cerebrospinal fluid interleukin (IL)-6 in unipolar major depression publication-title: J Affect Disord doi: 10.1016/S0165-0327(02)00460-3 – volume: 21 start-page: 479 issue: 5 year: 2011 ident: 10.1016/j.pnpbp.2014.01.013_bb0385 article-title: Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders publication-title: J Child Adolesc Psychopharmacol doi: 10.1089/cap.2011.0009 – volume: 82 start-page: 309 issue: 2 year: 2004 ident: 10.1016/j.pnpbp.2014.01.013_bb0145 article-title: Cytokine production in bipolar affective disorder patients under lithium treatment publication-title: J Affect Disord doi: 10.1016/j.jad.2004.01.007 – volume: 11 start-page: 328 issue: 4 year: 2009 ident: 10.1016/j.pnpbp.2014.01.013_bb0055 article-title: Exercise and bipolar disorder: a review of neurobiological mediators publication-title: Neuromolecular Med doi: 10.1007/s12017-009-8079-9 – volume: 13 start-page: 711 issue: 8 year: 2001 ident: 10.1016/j.pnpbp.2014.01.013_bb0400 article-title: Effect of repeated lipopolysaccharide administration on tissue cytokine expression and hypothalamic–pituitary–adrenal axis activity in rats publication-title: J Neuroendocrinol doi: 10.1046/j.1365-2826.2001.00684.x – volume: 24 start-page: 983 issue: 12 year: 2010 ident: 10.1016/j.pnpbp.2014.01.013_bb0665 article-title: Preventative strategies for early-onset bipolar disorder: towards a clinical staging model publication-title: CNS Drugs doi: 10.2165/11539700-000000000-00000 – volume: 70 start-page: 31 issue: 1 year: 2013 ident: 10.1016/j.pnpbp.2014.01.013_bb0890 article-title: A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers publication-title: JAMA Psychiatry doi: 10.1001/2013.jamapsychiatry.4 – volume: 19 start-page: 23 issue: 1 year: 2005 ident: 10.1016/j.pnpbp.2014.01.013_bb0875 article-title: Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2004.05.001 – year: 2013 ident: 10.1016/j.pnpbp.2014.01.013_bb0030 article-title: The effect of bariatric surgery on psychiatric course among patients with bipolar disorder publication-title: Bipolar Disord doi: 10.1111/bdi.12109 – volume: 10 start-page: 361 issue: 4 year: 1983 ident: 10.1016/j.pnpbp.2014.01.013_bb0565 article-title: Elevated levels of prostaglandin E2 and thromboxane B2 in depression publication-title: Prostaglandins Leukot Med doi: 10.1016/0262-1746(83)90048-3 – volume: 25 start-page: 1063 issue: 6 year: 2011 ident: 10.1016/j.pnpbp.2014.01.013_bb0355 article-title: Voluntary exercise protects hippocampal neurons from trimethyltin injury: possible role of interleukin-6 to modulate tumor necrosis factor receptor-mediated neurotoxicity publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2011.03.012 – volume: 13 issue: 175 year: 2013 ident: 10.1016/j.pnpbp.2014.01.013_bb0870 article-title: The association between diet quality, dietary patterns and depression in adults: a systematic review publication-title: BMC Psychiatry – volume: 134 start-page: 217 issue: 1–3 year: 2011 ident: 10.1016/j.pnpbp.2014.01.013_bb0750 article-title: Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression—no influence of celecoxib treatment publication-title: J Affect Disord doi: 10.1016/j.jad.2011.05.047 – year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb0005 – volume: 2 start-page: 525 issue: 5 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb0135 article-title: Gene expression profiles associated with depression in patients with chronic hepatitis C (CH-C) publication-title: Brain Behav doi: 10.1002/brb3.72 – volume: 14 start-page: 65 issue: 2 year: 2007 ident: 10.1016/j.pnpbp.2014.01.013_bb0755 article-title: Effect of the COX-2 inhibitor celecoxib on behavioural and immune changes in an olfactory bulbectomised rat model of depression publication-title: Neuroimmunomodulation doi: 10.1159/000107420 – volume: 70 start-page: 1078 issue: 8 year: 2009 ident: 10.1016/j.pnpbp.2014.01.013_bb0380 article-title: Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature publication-title: J Clin Psychiatry doi: 10.4088/JCP.08r04505 – volume: 141 start-page: 308 issue: 2–3 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb0010 article-title: Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study publication-title: J Affect Disord doi: 10.1016/j.jad.2012.03.033 – volume: 136 start-page: 443 year: 2002 ident: 10.1016/j.pnpbp.2014.01.013_bb0070 article-title: Serotonin brain circuits involved in major depression and suicide publication-title: Prog Brain Res doi: 10.1016/S0079-6123(02)36037-0 – volume: 12 issue: 6 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb0255 article-title: Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the depression, anxiety and stress scale (DASS) and the hospital, anxiety and depression scale (HADS) publication-title: BMC Psychiatry – volume: 41 start-page: 1436 issue: 5 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb0585 article-title: The association of asthma and wheezing with major depressive episodes: an analysis of 245 727 women and men from 57 countries publication-title: Int J Epidemiol doi: 10.1093/ije/dys123 – volume: 37 start-page: 222 issue: 2 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb0715 article-title: Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2012.02.002 – volume: 14 start-page: 650 issue: 6 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb0650 article-title: Obesity in bipolar disorder: an overview publication-title: Curr Psychiatry Rep doi: 10.1007/s11920-012-0313-8 – volume: 18 start-page: 227 issue: 3 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb0345 article-title: Refractoriness in bipolar disorder: definitions and evidence-based treatment publication-title: CNS Neurosci Ther doi: 10.1111/j.1755-5949.2011.00259.x – volume: 2 issue: 1 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb0940 article-title: Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2x2 clinical trial publication-title: BMJ Open doi: 10.1136/bmjopen-2011-000643 – volume: 147 start-page: 1656 issue: 12 year: 1990 ident: 10.1016/j.pnpbp.2014.01.013_bb1110 article-title: Psychiatric illness and irritable bowel syndrome: a comparison with inflammatory bowel disease publication-title: Am J Psychiatry doi: 10.1176/ajp.147.12.1656 – volume: 40 start-page: 171 issue: 4 year: 1999 ident: 10.1016/j.pnpbp.2014.01.013_bb0550 article-title: Cerebrospinal cytokine levels in patients with acute depression publication-title: Neuropsychobiology doi: 10.1159/000026615 – volume: 3 start-page: 41 year: 2012 ident: 10.1016/j.pnpbp.2014.01.013_bb0295 article-title: Microglial activation - tuning and pruning adult neurogenesis publication-title: Front Pharmacol doi: 10.3389/fphar.2012.00041 – volume: 61 start-page: 556 issue: 6 year: 2004 ident: 10.1016/j.pnpbp.2014.01.013_bb0920 article-title: Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.61.6.556 – volume: 8 start-page: 2980 issue: 7 year: 2011 ident: 10.1016/j.pnpbp.2014.01.013_bb0525 article-title: Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity publication-title: Int J Environ Res Public Health doi: 10.3390/ijerph8072980 – volume: 35 start-page: 702 issue: 3 year: 2011 ident: 10.1016/j.pnpbp.2014.01.013_bb0610 publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2010.12.017 – volume: 14 start-page: 248 issue: Suppl. 4 year: 2009 ident: 10.1016/j.pnpbp.2014.01.013_bb1145 article-title: Asthma, allergy, mood disorders, and nutrition publication-title: Eur J Med Res doi: 10.1186/2047-783X-14-S4-248 – volume: 36 start-page: 114 issue: 2 year: 2011 ident: 10.1016/j.pnpbp.2014.01.013_bb0980 article-title: Elevation of cerebrospinal fluid interleukin-1ss in bipolar disorder publication-title: J Psychiatry Neurosci doi: 10.1503/jpn.100080 – volume: 13 start-page: 13 issue: 1 year: 2010 ident: 10.1016/j.pnpbp.2014.01.013_bb0910 article-title: Exercise and adolescent mental health: new evidence from longitudinal data publication-title: J Ment Health Policy Econ – volume: 9 start-page: 759 issue: 7 year: 2007 ident: 10.1016/j.pnpbp.2014.01.013_bb1040 article-title: Plasma free polyunsaturated fatty acid levels are associated with symptom severity in acute mania publication-title: Bipolar Disord doi: 10.1111/j.1399-5618.2007.00387.x – volume: 19 start-page: 421 issue: 4 year: 2006 ident: 10.1016/j.pnpbp.2014.01.013_bb0325 article-title: Mood disorders: cardiovascular and diabetes comorbidity publication-title: Curr Opin Psychiatry doi: 10.1097/01.yco.0000228765.33356.9f – volume: 68 start-page: 167 issue: 2–3 year: 2002 ident: 10.1016/j.pnpbp.2014.01.013_bb0065 article-title: Mortality of patients with mood disorders: follow-up over 34–38years publication-title: J Affect Disord doi: 10.1016/S0165-0327(01)00377-9 – volume: 22 start-page: 1216 issue: 8 year: 2010 ident: 10.1016/j.pnpbp.2014.01.013_bb0080 article-title: Preventing late-life depression: a clinical update publication-title: Int Psychogeriatr doi: 10.1017/S1041610210000864 – volume: 13 start-page: 93 issue: 2 year: 2011 ident: 10.1016/j.pnpbp.2014.01.013_bb0970 article-title: Mood disorders and obesity: understanding inflammation as a pathophysiological nexus publication-title: Neuromolecular Med doi: 10.1007/s12017-010-8140-8 – volume: 87 start-page: 626 issue: 9 year: 2013 ident: 10.1016/j.pnpbp.2014.01.013_bb1130 article-title: Psoriasis publication-title: Am Fam Physician – volume: 29 start-page: 141 issue: 2 year: 1995 ident: 10.1016/j.pnpbp.2014.01.013_bb0600 article-title: Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers publication-title: J Psychiatr Res doi: 10.1016/0022-3956(94)00049-W – volume: 65 start-page: 732 issue: 9 year: 2009 ident: 10.1016/j.pnpbp.2014.01.013_bb0705 article-title: Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2008.11.029 – volume: 62 start-page: 25 issue: Suppl. 47 year: 2008 ident: 10.1016/j.pnpbp.2014.01.013_bb0645 article-title: Physical activity in the prevention and treatment of anxiety and depression publication-title: Nord J Psychiatry doi: 10.1080/08039480802315640 |
| SSID | ssj0001303 |
| Score | 2.5906126 |
| SecondaryResourceType | review_article |
| Snippet | Mood disorders have been recognized by the World Health Organization (WHO) as the leading cause of disability worldwide. Notwithstanding the established... |
| SourceID | proquest pubmed pascalfrancis crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 23 |
| SubjectTerms | Adult and adolescent clinical studies Animals Biogenic Monoamines - metabolism Biological and medical sciences Bipolar disorder Bipolar disorders Cytokines Cytokines - metabolism Depression Humans Inflammation Inflammation - complications Inflammation - metabolism Major depressive disorder Medical sciences Mood disorder Mood disorders Mood Disorders - complications Mood Disorders - metabolism Neuropharmacology Non-steroidal anti-inflammatory drug (NSAID) Pharmacology. Drug treatments Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry |
| Title | Inflamed moods: A review of the interactions between inflammation and mood disorders |
| URI | https://dx.doi.org/10.1016/j.pnpbp.2014.01.013 https://www.ncbi.nlm.nih.gov/pubmed/24468642 https://www.proquest.com/docview/1544007346 https://www.proquest.com/docview/1547537722 |
| Volume | 53 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBYhuRRKafrcpllUKDmtu7YsS3ZuS2jYtDQEuoHchCyNIKG1Tbw55JLf3pFkZ8kheyj4YqNBYp4aa-YTIV8tuv0yhSrRsjIJRmhAmytYYjFac-dSXoejmF_nYnnJf1wVVzvkZOyF8WWVg--PPj146-HLfODmvLu-nv_2Z2Y-fGKKEMoVfQc7l17Lvz1syjy8jw7_WaTvMOJiRB4KNV5d09UetDLjAbszy5-LTi873SPPXLzs4vndaIhKp6_Jq2E7SRdxxftkB5o35Ogi4lHfz-hq017Vz-gRvdggVd-_JauzxqFGgKV_29b2x3RBYysLbR3FnSH1YBK3sfWhp0NJF370RLHlkeomElM7wHj278jl6ffVyTIZrllIDFrvOnGlZo6l0mrLMmdYBnlZ1qnURhtXFZWRacVcAcICsFqA5EIbEI653EmQLn9Pdpu2gY-EghFW5i4HqAWXmP0Cz0vpXFbrWpiCTQgb2avMgEHur8L4o8ZisxsVZKK8TFSa4ZNPyOyRqIsQHNuHi1Fu6okmKQwS2wmnT6T8OBkrC3_vIZ-QL6PYFRqhP1nRDbR3vfKQRv7Mk4utYzA1xGQGufAh6sxmBkzKS8wEP_3v2g_IC_8WKhP5Z7K7vr2DQ9wtretpMIcp2Vuc_Vye_wPMmBVs |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBbp5tBCKH13-0hVKDmtWVuWJbu3JTTsNskS6AZyE7IekNDaJt4c8u8zeniXHLKHgk-yBhmN5mXNfIPQDw1qv0xNlUheqQQstAGZK0iiwVpTa1Na-6uY8yWbX9LfV8XVHjoeamFcWmXU_UGne20dR6ZxN6fd9fX0j7szc-YTQgSfrvgM7Tt0qmKE9meL0_lyo5Cdmva_WrgrMqJsAB_yaV5d09UOtzKjHr4zy58yUAed7GHbbOh38bRD6g3TySv0MnqUeBY--jXaM80bdHQRIKnvJ3i1rbDqJ_gIX2zBqu_fotWisXAojMb_2lb3P_EMh2oW3FoMziF2eBK3ofqhxzGrCwYdUah6xLIJxFhHJM_-Hbo8-bU6niex00KiQIDXiS0lsSTlWmqSWUUyk5dlnXKppLJVUSmeVsQWhmljSM0Mp0wqwyyxueWG2_w9GjVtYz4ibBTTPLe5MTWjHAJgQ_OSW5vVsmaqIGNEhu0VKsKQu24Yf8WQb3YjPE-E44lIM3jyMZpsiLqAwrF7Ohv4Jh4dJgF2Yjfh4SMubxYjZeFaH9Ix-j6wXYAcussV2Zj2rhcO1chde1K2cw5EhxDPwC58CGdmuwLE5SUEg5_-99u_oefz1fmZOFssTz-jF-6NT1SkX9BofXtnvoLztK4Po3A8ADoaGB0 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Inflamed+moods%3A+a+review+of+the+interactions+between+inflammation+and+mood+disorders&rft.jtitle=Progress+in+neuro-psychopharmacology+%26+biological+psychiatry&rft.au=Rosenblat%2C+Joshua+D&rft.au=Cha%2C+Danielle+S&rft.au=Mansur%2C+Rodrigo+B&rft.au=McIntyre%2C+Roger+S&rft.date=2014-08-04&rft.issn=1878-4216&rft.eissn=1878-4216&rft.volume=53&rft.spage=23&rft_id=info:doi/10.1016%2Fj.pnpbp.2014.01.013&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0278-5846&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0278-5846&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0278-5846&client=summon |